POPULARITY
Episode 191: Diagnosis of ADHDFuture Dr. Granat explains how to diagnose Attention Deficit Hyperactivity Disorder. She explained the influence of social media in increasing awareness of ADHD. Dr. Arreaza added input about the validated tools for ADHD diagnosis and highlighted the importance of expert evaluation for the diagnosis of this disorder. Written by Yen Stephanie Granat, MSIV. Ross University School of Medicine. Comments and editing by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Steph: I love podcasts—many of us do—and if you, like me, spend any amount of your leisure time listening to podcasts, perusing the news, or scrolling social media; you've likely noticed an alarming trend in the number of discussions we seem to be having about ADHD. It has grown into a very hot topic over the past couple of years, and for some of us, it seems to have even begun sneaking into our “recommended videos” and across our news feeds! Naturally, for the average person this can spur questions like:“Do I have ADHD? Do we all have it? How can I be certain either way, and what do I do if I find myself relating to most of the symptoms that I'm seeing discussed?”Granted that there is a whirlpool of information circulating around this hot topic, I was hoping to spend a bit of time clearly outlining the disorder for anyone finding themselves curious. I believe that can best be achieved through outlining a clear, concise, and easy-to-understand definition of what ADHD is; outlining what it is not; and helping people sift through the fact and the fiction. As with many important things we see discussed on the internet, we're seeing is that there is much more fiction than fact. Arreaza: I'm so glad you chose this topic! I think it is challenging to find reliable information about complex topics like ADHD. Tik Tok, Instagram and Facebook are great social media platforms, but we have to admit that fake news have spread like a fire in recent years. So, if you, listener, are looking for reliable information about ADHD, you are in the right place. With ADHD, there aren't any obvious indicators, or rapid tests someone can take at home to give themselves a reliable “yes” or “no” test result. People's concerns with ADHD are valid, and important to address, so we will discuss the steps to identify some of signs and symptoms they are seeing on TikTok or their favorite podcaster. Steph: Healthcare anxiety is a vital factor to consider when it comes to large cultural conversations around our minds and bodies; so, I hope to sweep away some of the misconceptions and misinformation floating around about ADHD. In doing so, I want to help alleviate any stress or confusion for anyone finding themselves wondering if ADHD is impacting their lives! We might even be able to more accurately navigate these kinds of “viral topics” (for lack of a better term) next time we see them popping up on our news feeds.Arreaza: The first thing I want to say about ADHD is “the crumpled paper sign.”Steph: What is that?Arreaza: It is an undescribed sign of ADHD, I have noticed it, and it is anecdotal, not evidence based. When I walk into a room to see a pediatric patient, I have noticed that when the paper that covers the examination table is crumpled, most of the times it is because the pediatric patient is very active. Then I proceed to ask questions about ADHD and I have been right many times about the diagnosis. So, just an anecdote, remember the crumpled paper sign. Steph: When you have patients coming to you asking for stimulants because they think they have ADHD, hopefully, after today, you can be better prepared to help those patients. So, for the average person—anyone wanting to be sure if this diagnosis applies to them—how can we really know?”Arreaza: So, let's talk about diagnosis.Steph: Yes, the clearest information we have is the DSM-5, which defines these disorders, as well as outlines the specific criteria (or “checkpoints”) one needs to meet to be able to have a formal diagnosis. However, this manual is best utilized by a trained professional—in this case, a physician—who can properly assess your signs and symptoms and give you a clear answer. Steph: ADHD stands for Attention Deficit Hyperactivity Disorder. It is among the most common neurodevelopmental disorders of childhood. That is not to say it does not affect adult—it does—and because it can be easy to miss, it's very possible for someone to have ADHD without knowing. Arreaza: I recently learned that ADD is an outdated term. Some people with ADHD do not have hyperactivity but the term still applies to them. Steph: Yes, there are multiple types that I will explain in just a bit. But overall the disorder is most simply characterized by a significant degree of difficulty in paying attention, controlling impulsive behaviors, or in being overly active in a way that the individual finds very difficult to control. (CDC)Arreaza: How common is ADHD?Steph: The most recently published data from The CDC estimates that 7 million (11.4%) of U.S. children between the ages of 3 and 17 have been diagnosed with ADHD. For adults, it is estimated that there are 15.5 million (6%) individuals in the U.S. who currently have ADHD. Arreaza: I suspected it would be more than that. [Anecdote about Boy Scout camp]. Steph: I totally agree. With short videos on TikTok, or paying high subscription fees to skip ads, it feels like as a society we all have a shorter attention span. Arreaza: Even churches are adapting to the new generation of believers: Shorter sermons and shorter lessons.Steph: When it comes to better understanding these numbers, it's also important to know that there are three distinct presentations of ADHD recognized by The CDC and The World Health Organization. Arreaza: The DSM-5 TR no longer uses the word “subtypes” for ADHD. Instead, it uses the word "presentation" to describe the different ways that ADHD may manifest in a person. That reminded me to update my old DSM-5 manual and I ordered it while reading today about ADHD. This means people with ADHD are no longer diagnosed as having a “subtype”. Instead, they are diagnosed with ADHD and a certain “presentation” of symptoms.Steph: These presentations are:Inattentive TypePeople often have difficulty planning or completing tasksThey find themselves easily distracted (especially when it comes to longer, focus-oriented tasks)They can often forget details and specifics, even with things that are part of their daily routineThis used to be referred to as “ADD” (you'll notice the absence of an “H”, segue).Hyperactive-Impulsive TypePeople often have a sense of intense “restlessness”, noticeable even in calm environments.They tend to be noticeably more talkative, and might often be seen interrupting others, or finishing their sentences.They find significant difficulty in being still for extended periods. Because of this, they are often unable to sit through a movie or class time, without fidgeting or getting up and moving around.With this category of ADHD, we often see an impulsiveness that unwittingly leads to risky behavior. Because of this, accidents and bodily injury are more common in individuals with this type of ADHD.Combined TypeThese are individuals who exhibit symptoms from both “Inattentive” and “Hyperactive-Impulsive” ADHD equally.Some listeners might have noticed that the categories are quite different, meaning that ADHD presents in different ways depending on the person! Two people who have ADHD can be in the same room and have vastly different presentations, whilst still having many of the same types of challenges. You also might have noticed what makes the discussion so interesting to the general public, which is also the thing that makes speaking to a professional to get formally tested so important:The diagnostic criteria rely heavily on patterns of behavior, or external variables; rather than on how a person might feel, or certain measurements taken from lab tests.Arreaza: Diagnosing ADHD requires evaluation by a professional who is properly trained for this. Fortunately, we have tools to assist with the diagnosis. The attention deficit must be noted in more than one major setting (e.g., social, academic, or occupational), that's why the information should be gathered from multiple sources, including parents, teachers, and other caregivers, using validated tools, such as:The Neuropsychiatric EEG-Based ADHD Assessment Aid (NEBA), recommended by the American Academy of NeurologyThe Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS) and the Vanderbilt ADHD Diagnostic Teacher Rating Scale (VADTRS), recommended by the Society for Developmental and Behavioral Pediatrics.For adults: The validated rating scales include the Adult ADHD Self-Report Scale (ASRS) and the Conners Adult ADHD Rating Scales (CAARS).Steph: This is important because nearly everyone alive has experienced several, if not most, of these behavioral patterns at least once. Whether or not an individual has ADHD, I'm certain we could all think of moments we've had great difficulty focusing or sitting still. Perhaps some of us are incredibly forgetful, or act more impulsively than the average person might find typical. Getting a professional diagnosis is important because it is in skillfully assessing “the bigger picture” of a person's life, or their patterns of behavior, that a skilled physician, who understands the nuances and complexities in these disorders, can properly tell each of us whether we have ADHD, or not.Essentially, most of us could stand to use a bit more focus these days, but far fewer of us would meaningfully benefit from the kinds of treatments and therapies needed by individuals with ADHD to live healthier, more happy and regulated lives.Arreaza: I had a mother who came to discuss the results of the Vanderbilt Questionnaire. I think she left a little disappointed when she heard that, based on the responses from her and the teacher, her son did not have ADHD. Some kids may have behaviors such as being distracted during a meeting, forgetting about homework or having a lot of energy, but that does NOT mean necessarily that they have ADHD, right?Steph: Absolutely! The important thing to remember here is that these patterns of behavior outlined in the DSM-5 are merely an external gauge for a neurological reality. What the science is showing us is that the brains of people with ADHD are wired differently than that of the more “neurotypical” brain. Much like a check engine light would serve as a signal to a driver that something under the hood needs attention; these patterns of behavior, when they begin impeding our day to day lives, might tell us that it's time to see a professional (whether it be an auto mechanic or a trained physician). I think we all know someone who drives with their check engine light and not a care in the world. Arreaza: How serious/urgent is ADHD? Why should we care to make the diagnosis?Steph: Although we've yet to see anyone incur harm solely from having ADHD, it does lead to quite a range of more serious issues, some of which might prove more urgent. In the cases of ADHD, specifically, what we know is that there is a notable degree of dysregulation in some key neurotransmitters, like dopamine and norepinephrine. More plainly, what we are seeing in the brains of people with ADHD is a disruption, or alteration, of some of the brain's key chemicals.These neurotransmitters are largely responsible for much-needed processes like Motivation, Satisfaction, Focus, Impulse control, even things like energy and feelings of happiness. Many of these things serve as “fuel” for our day-to-day lives; things we'd call our “executive function”. These are also what prove dysfunctional in those struggling with ADHD. It is in this sense that we might be able to bridge a meaningful gap between ADHD as being seen through patterns of behaviorthat signal a real, neurological reality.Steph: We often hear of the brain referenced as a kind of supercomputer. A more accurate assessment might be that the brain is more of a network of interconnected computers that run different processes and require continual communication with one another for our brain to function properly and seamlessly. What we're seeing in members of the population with this diagnosis, is a significant disruption in these lines of communication. Although this is a very broad oversimplification, for the purposes of our metaphor is to think of it like our brain chemicals getting caught in a traffic jam, or parts of our brain attempting to communicate to one another with poor cell signal. Arreaza: Making the diagnosis is critical to start treatment because having that level of dysfunction sounds like having a very difficult life.Steph: Yeah! I think that's why this conversation matters so much. There's a sense of urgency there, because much of life is, in fact, boring. Things like paying bills, exercising and eating well, work and school—these are all things that are vital to health and wellbeing in day-to-day life; and for the more neurotypical brain, these things might prove occasionally challenging. Yet, they are still doable. For those with ADHD however, this goes far beyond mere boredom or “laziness” (which proves to be a trigger term for many—more on that in just a bit).For folks listening, I wanted to offer some statistics that show why this is such a big concern for the public, whether one has a formal ADHD diagnosis or not. The facts are figures are:Children with ADHD are more than five times as likely as the child without ADHD to have major depression.A significant increase in the prevalence of anxiety is seen in ADHD patients, ranging from 15% to 35%, when accounting for overlap in symptoms.There are significant correlations in youth diagnosed with ADHD, and those diagnosed with what are known as “externalizing disorders”. These are things like Conduct Disorder, Disruptive Mood Dysregulation Disorder, and Oppositional Defiant Disorder.We are seeing a much higher rate of academic problems in kids who have ADHD, like reading disorder, impaired verbal skills, and visual motor integration.We're finding that many, if not most, of these connections are being made after diagnosis. In the case of the “internalized disorders”, like depression and anxiety, we're often seeing years between ADHD diagnoses and the diagnoses of major depressive disorder or anxiety disorders. Given this framework, much of the data is theorized to point towards what we call “negative environmental circumstances”, otherwise known as “ADHD-related demoralization”.For children, this often looks like struggling with sitting still during class, failing to get homework done (because they forgot, or couldn't focus on the tasks at hand), and struggling to focus their attention on what their teacher is saying during lecture. These things often lead to bad grades, discipline or forced time sitting still in detention. This can be seen in more problems at home, with children being disciplined often for behavior that they struggle immensely to control.For adults, this can mean forgetting to pay your bills, missing work meetings, having trouble making appointments, or having difficulty with day-to-day tasks, really anything that requires sustained attention. We often see adults with ADHD who are chasing normalcy with caffeine addictions or even struggling with substance use. Arreaza: Substance use disorder actually can be a way for some people living with ADHD to self-treat their symptoms. Steph: These differences between the individual's experience and the world around them can lead to really powerful feelings of failure or inadequacy. They can affect your social life, your sense of community, and even further limit your capacity to seek help.Literacy in these things is so important—not just for the individual who feels that they may have ADHD, but also for those who are likely to encounter people with ADHD in their own lives. Understanding why some of these patterns pop up, even those who might not have a formal diagnosis, can go a long way to properly approaching these behaviors with success and with empathy.Arreaza: Learning about ADHD is fundamental for primary care doctors. We talked about the high prevalence and the influence of the media in increasing awareness and sometimes increasing public panic. So, we have to be prepared to diagnose or undiagnosed ADHD. Steph: Whether we're the physicians in the room, or the patient in the chair, I think it's important to have a clear understanding of what ADHD is and how it can affect lives. Thanks for listening, I hope we were able to teach you a little more about ADHD. ______________Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _______________References:NICHQ-Vanderbilt-Assessment-Scales PDF: https://nichq.org/wp-content/uploads/2024/09/NICHQ-Vanderbilt-Assessment-Scales.pdfADHD: The facts. ADDA - Attention Deficit Disorder Association. (2023, January 11). https://add.org/adhd-facts/American Psychiatric Association, DSM-5 Task Force. (2013). Diagnostic and statistical manual of mental disorders: DSM-5™ (5th ed.). American Psychiatric Publishing, Inc. https://doi.org/10.1176/appi.books.9780890425596.Gnanavel S, Sharma P, Kaushal P, Hussain S. Attention deficit hyperactivity disorder and comorbidity: A review of literature. World J Clin Cases. 2019 Sep 6;7(17):2420-2426. doi: 10.12998/wjcc.v7.i17.2420. PMID: 31559278; PMCID: PMC6745333.Staley BS, Robinson LR, Claussen AH, et al. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October – November 2023. CDC.Gov, MMWR Morb Mortal Wkly Rep 2024;73:890-895.Danielson ML, Claussen AH, Arifkhanova A, Gonzalez MG, Surman C. Who Provides Outpatient Clinical Care for Adults With ADHD? Analysis of Healthcare Claims by Types of Providers Among Private Insurance and Medicaid Enrollees, 2021. J Atten Disord. 2024 Jun;28(8):1225-1235. doi: 10.1177/10870547241238899. Epub 2024 Mar 18. PMID: 38500256; PMCID: PMC11108736. https://pubmed.ncbi.nlm.nih.gov/38500256/Mattingly G, Childress A. Clinical implications of attention-deficit/hyperactivity disorder in adults: what new data on diagnostic trends, treatment barriers, and telehealth utilization tell us. J Clin Psychiatry. 2024;85(4):24com15592. https://www.psychiatrist.com/jcp/implications-adult-adhd-diagnostic-trends-treatment-barriers-telehealth/Didier J. My four kids and I all have ADHD. We need telehealth options. STAT News. Published October 10, 2024. Accessed October 10, 2024. https://www.statnews.com/2024/10/10/adhd-medication-shortage-telehealth-dea-congress/.Hong J, Mattingly GW, Carbray JA, Cooper TV, Findling RL, Gignac M, Glaser PE, Lopez FA, Maletic V, McIntyre RS, Robb AS, Singh MK, Stein MA, Stahl SM. Expert consensus statement for telepsychiatry and attention-deficit hyperactivity disorder. CNS Spectr. 2024 May 20:1-12. doi: 10.1017/S1092852924000208. Epub ahead of print. PMID: 38764385. https://pubmed.ncbi.nlm.nih.gov/38764385/Gabor Maté: The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture. (2022). Youtube. Retrieved April 27, 2025, from https://www.youtube.com/watch?v=ttu21ViNiC0. Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.
On March 31, 1918, the United States did something they'd never done before. They moved their clocks. Yes, it was the first time Daylight Savings Time was observed. Why did it start and why is it still going? And, what else was making headlines on the same day sleep cycles all over the country got a little messed up?SOUND SOURCES“Advertisement: Idaho Power Company.” The Idaho Statesman (Boise, Idaho), March 31, 1918. ww.newspapers.com.“Ancestry.Com: Drafts, Censuses, Divorce Records.” 1940 United States federal census - ancestry.com. Accessed October 10, 2024.https://www.ancestry.com/discoveryui-content/view/425845:2442. “Capt. Albert Barr Now In Camp Hospital.” The Virginian-Pilot (Norfolk, Virginia), April 30, 1918. www.newspapers.com.“Capt. at Sevier Lived On Berries.” The State (Columbia, South Carolina), May 10, 1918. www.newspapers.com.“Capt. Barr of Camp Sevier Is Missing.” The Commercial Appeal (Memphis, Tennessee), March 31, 1918. www.newspapers.com.“Collyer Murder Due To Quarrel.” The Saline Evening Journal (Salina, Kansas), March 21, 1918. www.newspapers.com.“Daylight Saving Time.” Wikipedia, October 8, 2024.https://en.wikipedia.org/wiki/Daylight_saving_time#:~:text=DST%20was%20first%20implemented%20in%20the%20US%20with%20the%20Standard,hours%20to%20conserve%20energy%20resources.“Daylight-Saving Law, Effective Today, Will Add HugeSums to Our War Chest.” Los Angeles Sunday Times (Los Angeles, California), March 31, 1918. www.newspapers.com.Fore, Samuel K. “Camp Sevier.” South Carolina Encyclopedia, July 20, 2022. https://www.scencyclopedia.org/sce/entries/camp-sevier/. “Gets Light Punishment.” The Atchison Daily Globe (Atchison, Kansas), April 1, 1918. www.newspapers.com.“Girl Fires Fatal Shot.” The Logan Republican (Logan, Kansas), February 14, 1918. www.newspapers.com.“Jury Disagrees In Madeline Briggs Case.” The Daily Guard (Council Grove, Kansas), March 25, 1918. www.newspapers.com.“Jury Has Briggs Case Again.” The Kansas City Star (Kansas City, Missouri), March 31, 1918. www.newspapers.com.“Madeline Briggs Murder Trial.” The Oakley Graphic (Oakley, Kansas), March 22, 1918. www.newspapers.com.“Madeline Briggs Sentenced to Pen.” The Daily Republican (Burlington, Kansas), April 15, 1918. www.newspapers.com.“Mrs. Briggs of Collyer Dies.” The Kansas City Times (Kansas City, Missouri), May 4, 1918. www.newspapers.com.“Says Hun Spies Tried Murder.” The Brooklyn Daily Times (Brooklyn, New York), April 2, 1918. www.newspapers.com.“She Shot to Kill.” Abilene Daily Chronicle (Abilene, Kansas), January 29, 1918. www.newspapers.com.“Spy Story Not Truth, Woman Now Declares.” TheBuffalo News (Buffalo, New York), April 3, 1918. www.newspapers.com.“Why Do We Have Daylight Saving Time?” History.com.Accessed October 10, 2024. https://www.history.com/news/why-do-we-have-daylight-saving-time. “Woman Arrested As Spy Admits Act of Air Espionage.” The Arizona Republic (Phoenix, Arizona), March 31, 1918. www.newspapers.com.SOUND SOURCESAl Jolson. “I'll Say She Does.” www.pixabay.com/music.Lucille Hegamin and The Dixie Daisies. “Cold Winter Blues.” www.pixabay.com/music.Sophie Tucker. “Reuben Rag.” www.pixabay.com/music.
On March 18, 1925, a massive tornado (that would become known as the Tri-State Tornado) touched down in parts of Missouri, Illinois, and Indiana. It would go down in history as the world's deadliest tornado. What else was making headlines on such a horrible day?SOURCES“Advertisement: Pacific Gas and Electric Company (Page 2).” Daily Gazette (Martinez, California), March 18, 1925. www.newspapers.com.“Annapolis, Missouri.” Wikipedia, May 11, 2024.https://en.wikipedia.org/wiki/Annapolis,_Missouri. “Arrest Neponset Man As Jack the Hugger.” The Boston Globe (Boston, Massachusetts), February 3, 1925. www.newspapers.com.Associated Press. “Rules Shepherd Is McClintock's Heir.” The Decatur Daily Review (Decatur, Illinois), October 28, 1926. www.newspapers.com.Blakemore, Erin. “The Deadliest Tornado in US History Blindsided the Midwest in 1925.” History.com. Accessed October 8, 2024.https://www.history.com/news/deadliest-tornado-tri-state-1925-united-states. “Chronology of McClintock Murder Case.” Streator Daily Free Press (Streator, Illinois), May 26, 1925. www.newspapers.com.Gibbons, Roy J. “Free Press Reporter Spends Day In Jail With Shepherd.” Streator Daily Free Press (Streator, Illinois), May 26, 1925. www.newspapers.com.“He Hugged Two At Once.” The Tribune (Scranton, Pennsylvania), June 29, 1925. www.newspapers.com.“Home Folk Will Not Believe Mrs. Shepherd a ‘Lady MacBeth.'” Streator Daily Free Press (Streator, Illinois), May 26, 1995. www.newspapers.com.“Jack the Hugger.” The Evening Courier (Camden, New Jersey), December 15, 1925. www.newspapers.com.“Law Forges Strong Chain Around William Shepherd Accused of Murdering Last of McClintock Family to Get Great Fortune Which Some Say Carries Curse.” The Brooklyn Eagle (Brooklyn, New York), March 22, 1925. www.newspapers.com.“Mother and Baby Blown to Tree Top by Tornado, but Escape by Miracle.” The Commercial Appeal (Memphis, Tennessee), March 20, 1925. www.newspapers.com.“Police Seek Hugger After Two Attacks.” Wilkes-Barre Times Leader (Wilkes-Barre, Pennsylvania), March 18, 1925. www.newspapers.com.“Several Reported Killed By Tornado at Annapolis, MO.” Springfield Leader and Press (Springfield, Missouri), March 18, 1925. www.newspapers.com.“Three Held, Others Sought in Mine Blast; Little Hope Held for 34 Men.” Pittsburgh Post-Gazette (Pittsburgh, Pennsylvania), March 19, 1925. www.newspapers.com.“Tornado, Fire, Flood, and Mine Disasters Take Big Toll In Day.” Pittsburgh Post-Gazette (Pittsburgh, Pennsylvania), March 10, 1925. www.newspapers.com.United Press.“Shepherd Given Freedom Under Bond As Jury Acquits Him of Charge of Murder.” Belvidere Daily Republican (Belvidere, Illinois), June 27, 1925. www.newspapers.com.US Department of Commerce, NOAA. “1925 Tornado.” National Weather Service, March 5, 2015. https://www.weather.gov/pah/1925Tornado_iq. US Department of Commerce, NOAA. “1925 Tornado.” National Weather Service, March 5, 2015.https://www.weather.gov/pah/1925Tornado_ss. “William Darling ‘Darl' Shepherd .” Find a Grave. Accessed October 8, 2024. https://www.findagrave.com/memorial/203215798/william-darling-shepherd. SOUND SOURCESAl Jolson. “I'll Say She Does.” www.pixabay.com/music.Lucille Hegamin and The Dixie Daisies.“Cold Winter Blues.” www.pixabay.com/music.Sophie Tucker. “Reuben Rag.” www.pixabay.com/music.
One of the greatest engineering marvels of the 20th century - the Hoover Dam - was dedicated on September 30, 1935. What did the project mean for the United States, and what else was happening around the country and world on the exact same day?SOURCES“4 O'clock Bulletins.” Holyoke Daily Transcript (Holyoke, Massachusetts), August 3, 1936. www.newspapers.com.“5 Shot in Bank Raid; Tear Gas Routs Gang of 9.” Chicago Daily Tribune (Chicago, Illinois), October 1, 1935. www.newspapers.com.Associated Press. “Five Shot During Bank Robbery.” The Sheboygan Press (Sheboygan, Wisconsin), September 30, 1935. www.newspapers.com.Associated Press. “Hoover Dam's Dedication Is Staged Today.” Tucson Citizen (Tucson, Arizona), September 30, 1935. www.newspapers.com.Associated Press. “Newell Sherman Drowns In Chair for Drowning of Wife.” The Springfield Daily Republican (Springfield, Massachusetts), August 4, 1936. www.newspapers.com.Associated Press. “Sherman Counsel Sums Up Defense Before the Jury.” The Daily Evening Item(Lynn, Massachusetts), September 30, 1935. www.newspapers.com.Associated Press. “Weston Gets Life For Loll Slaying.” The Oregon Statesman (Salem, Oregon), January 28, 1936. www.newspapers.com.“Confession of Newell Sherman.” The Boston Globe (Boston, Massachusetts), July 22, 1935. www.newspapers.com.“The Controversial Naming of the Dam.” PBS. Accessed September 25, 2024. https://www.pbs.org/wgbh/americanexperience/features/hoover-controversy/. “Deputy Sheriff Ernest Loll.” Multnomah County Sheriff's Office, February 1, 2024. https://www.mcso.us/about-mcso/fallen-deputies/ernest-loll. “George Leonard Fiedler (1912-1957) .” Find a Grave. Accessed September 30, 2024. https://www.findagrave.com/memorial/234373940/george-leonard-fiedler. “Hoover Dam.” Wikipedia, August 28, 2024.https://en.wikipedia.org/wiki/Hoover_Dam#:~:text=Hoover%20Dam%20is%20a%20concrete,Roosevelt.“Mrs Alice Doris Dudley Sherman (1912-1935) - Find...” Find a Grave. Accessed October 1, 2024. https://www.findagrave.com/memorial/74472032/alice_doris_sherman. “Mrs. Fiedler Says Son Told of Shooting.” The Oregon Daily Journal (Portland, Oregon), October 2, 1935. www.newspapers.com.“Reward Offered In Slaying.” The Oregon Daily Journal (Portland, Oregon), September 30, 1935. www.newspapers.com.“Stained Weapon Clue to Murder.” The Oregonian (Portland, Oregon), October 1, 1935. www.newspapers.com.United Press. “Boulder Dam to Be Dedicated Today.” Nevada State Journal (Reno, Nevada), September 30, 1935. www.newspapers.com.“Weston Murder Jury Selected.” The Oregon Daily Journal (Portland, Oregon), January 18, 1936. www.newspapers.com.“Witnesses Tell About Fatal Hunt.” The Oregon Daily Journal (Portland, Oregon), January 18, 1936. www.newspapers.com.“‘The Greatest Dam in the World': Building Hoover Dam (Teaching with Historic Places) (U.S. National Park Service).” National Parks Service. Accessed September 25, 2024.https://www.nps.gov/articles/-the-greatest-dam-in-the-world-building-hoover-dam-teaching-with-historic-places.htm.SOUND SOURCESAl Jolson. “I'll Say She Does.” www.pixabay.com/music.Lucille Hegamin and The Dixie Daisies. “Cold Winter Blues.” www.pixabay.com/music.Sophie Tucker. “Reuben Rag.” www.pixabay.com/music.
Send us a textRising seas. Dredged rivers. Dying forests. In this episode of Shoresides, we investigate one of North Carolina's most subtle yet devastating climate threats: ghost forests. These vast expanses of standing dead trees are creeping inland, driven by rising sea levels and relentless dredging of the Cape Fear River.UNCW scientists Monica Rother and Andrea Hawks join us to explain how their research—combining tree ring data and microscopic marine organisms—paints a stark picture of environmental change. They discuss why ghost forests are spreading, how they disrupt ecosystems, and what it means for communities, flooding, and environmental justice across the region.Rother and Hawks are at the forefront of research on North Carolina's ghost forests, using innovative methods to track the impact of climate change and human activity on coastal ecosystems. Rother, a forest ecologist and tree ring scientist, analyzes tree growth patterns to understand long-term environmental changes, revealing how rising salinity levels stress and ultimately kill freshwater trees. Hawks, a micropaleontologist, studies tiny marine organisms preserved in sediment to reconstruct past sea level changes and pinpoint when saltwater intrusion began affecting these landscapes. Together, their interdisciplinary work provides a clearer picture of how dredging and rising seas accelerate the spread of ghost forests, offering crucial insights into the future of coastal resilience and community health.Learn more...1. Ghost forests are dead tree stands caused by rising salinity. These eerie landscapes form when saltwater intrusion—driven by rising sea levels, coastal erosion, and human activities like dredging—kills freshwater-dependent trees, leaving behind lifeless trunks.2. They are a visible sign of climate change. Ghost forests are one of the most striking indicators of global warming, as they mark areas where land is transitioning from forest to marsh due to sea-level rise and increasing storm surges.3. The Cape Fear River dredging accelerates ghost forest formation. In Wilmington, NC, repeated deepening of the Cape Fear River has allowed tides to push saltwater farther inland, increasing salinity in freshwater wetlands and rapidly killing off bald cypress and other trees.4. They disrupt ecosystems and increase flooding risks. The loss of forested wetlands means less natural flood protection, leading to higher flood risks for nearby communities. 5. Ghost forests are expanding along the East and Gulf Coasts. While they are particularly noticeable in North Carolina, ghost forests are appearing from the Mid-Atlantic to the Gulf Coast.Useful articles...1. Bernhardt, E. (2022, June 29). “Coastal freshwater wetlands squeezed between migrating salt marshes and working lands.” Science Advances, 8(26).2. Carolina Public Press (2022, August 12). “‘Ghost forests' are creeping across NC's coast at an alarming rate. Researchers are trying to stop them.” Accessed October 29, 2024.3. Coastal Review (2022, June 15). “Research network to link enSupport the showwww.shoresides.org
Episode 180: Pediatric Hip PainFuture Dr. Pena-Brockett explains the differential diagnosis in a 14-year-old patient who has a new onset of left hip pain. Dr. Arreaza adds comments and explains toxic synovitis. Written by Natalie Pena-Brockett, MSIV, California Health Sciences University. Comments by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Having a limping kid can be terrifying. Many questions may cross your mind: Is this a permanent damage? What is going on here? Where is the pain located? Do I need to send this child to the hospital? Today, hopefully, we can help you ease some of your fears. Case: This is a 14-year-old boy with no past medical history, no trauma, presents to the family medicine clinic with a complaint of left-sided hip pain. Mom notes that her son has been limping for the last week and complaining of pain in his left hip and knee when he walks. He has never experienced this pain before this week. He does not take any medications. Physical exam: He is afebrile and all of his vitals are within normal limits. On exam, you note that his BMI is at the 90th percentile (overweight), and has an antalgic gait where he is favoring the right side and has tenderness on his left groin. His left foot is turned outward while standing up straight. His left knee has negative findings on specialized tests, but he has restricted movement of the left hip. Discussion: This is a common topic that you will see on board exams or limping into your office. Although pediatric hip pain may seem like a benign musculoskeletal concern, taking the time to take a complete history and perform a thorough physical exam is critical to assess the severity of the patient's concern.Physical Exam for Pediatric Hip Pain.Observation: Every physical exam begins the moment you first see the patient. This allows you to gauge the patient's comfort level, the natural stature, length, and positioning of the patient's extremities, skin changes, gait, and ability to bear weight. Palpation: In medicine, our hands are one of our greatest tools for evaluating patients, especially those with musculoskeletal concerns. This is the time to palpate the area for any tenderness or gross deformities of the pelvis, hip, knee, or leg. Special Tests: In the world of MSK, we have all sorts of tests to evaluate the range of movement of our joints and tendons. When specifically evaluating the hip, the most common are the FABER(flexion, abduction, external rotation),test to assess the sacroiliac joint, Ober's Test to assess the iliotibial band, and Straight Leg Raise to assess for lumbar radiculopathy.Legg-Calve Perthes Disease-Legg-Calve Perthes disease is an idiopathic avascular necrosis of the femoral head. -It is most commonly observed in patients between the ages of 2-12 years and in a higher ratio of males to females 1. -It often manifests as an atraumatic limp with limited movement in abduction and internal rotation. -X-ray imaging may demonstrate a widening of the joint space and sclerosis of the femur, and MRI will confirm osteonecrosis of the femoral head. -Early diagnosis is key to minimizing the risk of developing osteoarthritis of the hip. -The goal of treatment is to maintain the shape of the femoral head and the range of motion of the hip. -The first-line treatment includes managing pain with NSAIDs, limiting weight-bearing activity, and physical therapy for range of motion.-If the disease progresses, bracing and casting can be used to retain the femoral head within the acetabulum to keep the shape and integrity of the femoral head. In more serious cases, a surgical osteotomy may be done to cut and realign the bones. Developmental Dysplasia of the Hip (DDH)-Developmental Dysplasia of the Hip (DDH) is a pediatric condition that results in unilateral or bilateral instability of the hip due to the abnormal development of the acetabulum or femur. -This is most commonly seen in newborns, especially those which develop in a breech position. -These patients often present with a shortened leg or asymmetric gluteal creases and a Trendelenburg gait when walking. -The Trendelenburg gait is an abnormal gait caused by weak hip abductor muscles. The person's trunk shifts over the affected hip during the stance phase of walking and away from it during the swing phase, making it look like the person is missing steps or limping. -On physical exam, hip joint laxity can be evaluated with the Ortolani and Barlow maneuvers to apply pressure to the proximal femur to assess dislocatability of the hip joints. These maneuvers would both be considered positive if a “clunk” is felt over the hip as this means that the hip is dislocated with pressure. Due to the patient's age usually being under 6 months old, ultrasound is the most common imaging modality to confirm the diagnosis, otherwise, an X-ray can be used. -The treatment in patients under 18 months old, a Pavlik Harness is often used to treat patients to maintain the placement of the hip within the acetabulum. -Patients between the ages of 18 months and 9 years old, are most often treated with open or closed reduction of the hip. -There is generally less success in reduction treatment of children older than 9 years old as they have likely developed femoral head deformities and are at greater risk of osteonecrosis. -Children with DDH should continue to be monitored with regular imaging to evaluate for complications. These patients should also be made aware that they are also at increased risk of requiring a hip replacement, especially if their treatment included a reduction. 2Slipped Capital Femoral Epiphysis (SCFE)-Slipped Capital Femoral Epiphysis (SCFE) is one of the most common pediatric hip pathologies in which the capital femoral epiphysis is anterolaterally displaced from the femoral neck. -Although slightly more common in males than females between the ages of 10 to 16, the greatest risk factor for an SCFE is childhood obesity 3. -Common symptoms include an insidious onset of unilateral hip pain and a change in gait due to the displacement of the hip from the acetabulum. In some instances of chronic SCFE, some patients will experience ipsilateral knee pain due to compensation. -A SCFE can be evaluated with an AP radiograph which will demonstrate a widened physis in the early stages or the classic “slipped ice cream cone sign” which is the posterior displacement of the femoral epiphysis. -Management of a SCFE includes limiting weight-bearing activities as well as screw fixation by an orthopedic surgeon to stabilize the hip.Patients should consider pinning the contralateral hip due to increased risk of developing a future SCFE. Early diagnosis is critical as untreated SCFE can lead to osteonecrosis.Osgood-Schlatter-Osgood-Schlatter is a repetitive-use pediatric condition as a result of traction to the growth plate of the tibial tubercle. -This pathology is most common in male children between the ages of 9 to 14 years old 4. -Active athletes or children with rapid growth spurts are at greater risk of developing Osgood-Schlatter than non-active children.-These children often present with an achy knee pain that can lead to a unilateral limping gait. On physical exam, these patients often have a bony prominence over the tubercle that is tender to palpation with greater tenderness over the patellar tendon. -The knee will have full range of motion and stability, but will likely have a warmth and erythema over the knee. Imaging of the knees can have nonspecific findings and diagnosis is made clinically. -For management, it is recommended that children continue their regular activities and rest with NSAIDs for pain management as needed 5. Physical therapy can be prescribed to prevent deconditioning as this can result in recurrence or additional injuries.Arreaza: It seems like the pain is more localized to the knee, but it can be referred to the hip. If you have tenderness on the tibial tubercle, you got the diagnosis. Juvenile Idiopathic Arthritis (JIA)-Juvenile Idiopathic Arthritis (JIA) is a systemic rheumatologic condition in children that often presents as a polyarticular pain. The onset of disease is often bimodal with peaks between 2 to 5 years old and 10 to 14 years old. 6-Patients will often complain of minor symmetric joint pain and stiffness until an infection causes an inflammatory reaction that exacerbates the joint pain or can increase joint involvement. Small joints are the most likely to be involved, but hips and knees can also be affected. -Lab evaluation will demonstrate inflammation with an elevated ESR, low hemoglobin, and a positive ANA. -Disease management starts with NSAIDS for pain control and can escalate to immunosuppressive measures for moderate disease7.Toxic Synovitis-Toxic synovitis, also known as transient synovitis, is the leading cause of acute hip pain and limping in children aged 2–12, more commonly affecting boys. -This self-limited inflammatory condition, often confused by its name as "toxic," has no relation to a toxic state. It typically arises after an upper respiratory or other viral infection (e.g., rubella or coxsackie virus).-Children with toxic synovitis may show mild to moderate hip pain, limp, and keep their hip in abduction and external rotation. Movement is usually possible within a limited range, and weight-bearing is often maintained.-Evaluation: A thorough history and physical exam are key, as laboratory tests like CBC, ESR, and CRP are often normal, mainly used to rule out other conditions like septic arthritis. X-rays typically show no abnormalities, although small changes may appear. Ultrasound can help detect joint effusion and rule out septic arthritis if no effusion is present.Arreaza: DDX: DDH, SCFE, Osgood Schlatter, and toxic synovitis.Osteopathic Manipulative Treatment in Pediatric Hip PathologiesSacroiliac Articulatory Technique- this is a technique in which you move the joint into an out of its barrier to reduce restriction and improve movementCounterstrain of Tender points (psoas, piriformis, hip adductors)- in this technique we shorten the muscle to decrease tension. This allows the muscle to increase blood lymphatic flow to reduce nociceptive and proprioceptive activity of the muscleBalanced Ligamentous Tension of the Innominate- with this technique, we manipulate the joint in a way that moves the ligaments into neutral position so that there is balance in all planes of motion. The goal is to again release tension within the muscles and the jointClinical Decision Making Now that we have covered the most common differential diagnoses for pediatric hip pain, let's revisit our patient presentation and identify the key characteristics to determine which diagnosis he most likely has.The patient is 14 years old. This makes DDH and Legg-Calve Perthe less likely, and SCFE more likely.He has been complaining of symptoms for 1 week, which indicates that is not likely a chronic condition. This makes DDH and Osgood-Schlatter less likely.The patient has never experienced joint pain like this before. This makes JIA, DDH, and Osgood-Schlatter less likely.The patient is overweight. This makes SCFE more likely.The unilateral hip tenderness and no knee pain. This makes Osgood-Schlatter and JIA less likely.The patient has antalgic gait and limited internal rotation of the foot. This makes Legg-Calve Perthes and SCFE more likely. Now when we take the epidemiological factors, the history of the present illness, and the physical exam findings into account, this patient's presentation best aligns with a SCFE. We would order a bilateral AP and Frog-leg views of the hips. If either imaging shows a widened physis or the classic “ice cream cone sign”, this is when we would start the referral process for an orthopedic surgery consultation for internal fixation. As family medicine physicians, we would give instructions for strict non-weight bearing activities and analgesics or anti-inflammatories for pain management.Keep in mind some of the DDX: Calve Legg-Perthes disease, Developmental Dysplasia of the Hip (DDH), Juvenile Idiopathic Arthritis (JIA), Osgood Schlatter, toxic synovitis, and Slipped Capital Femoral Epiphysis (SCFE). Hopefully, the next time you have a pediatric patient present with a complaint of hip pain, you'll feel more comfortable evaluating and working up the case._________________________This week we thank Hector Arreaza and Natalie Pena-Brockett. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Osteonecrosis of the femoral head / Legg-Calvé-Perthes disease | Time of Care. Accessed October 27, 2024. https://www.timeofcare.com/osteonecrosis-of-the-femoral-head-legg-calve-perthes-disease/Scott EJ, Dolan LA, Weinstein SL. Closed Vs. Open Reduction/Salter Innominate Osteotomy for Developmental Hip Dislocation After Age 18 Months: Comparative Survival at 45-Year Follow-up. J Bone Joint Surg Am. 2020;102(15):1351-1357. doi:10.2106/JBJS.19.01278. https://europepmc.org/article/med/32769602Perry DC, Metcalfe D, Costa ML, Van Staa T. A nationwide cohort study of slipped capital femoral epiphysis. Arch Dis Child. 2017;102(12):1132-1136. doi:10.1136/archdischild-2016-312328. https://pubmed.ncbi.nlm.nih.gov/28663349/Haines M, Pirlo L, Bowles K-A, Williams CM. Describing Frequencies of Lower-Limb Apophyseal Injuries in Children and Adolescents: A Systematic Review. Clin J Sport Med. 2022;32(4):433-439. doi:10.1097/JSM.0000000000000925. https://pubmed.ncbi.nlm.nih.gov/34009802/Wall EJ. Osgood-Schlatter disease: practical treatment for a self-limiting condition. Phys Sportsmed. 1998;26(3):29-34. doi:10.3810/psm.1998.03.802. https://pubmed.ncbi.nlm.nih.gov/20086789/Oberle EJ, Harris JG, Verbsky JW. Polyarticular juvenile idiopathic arthritis - epidemiology and management approaches. Clin Epidemiol. 2014;6:379-393. doi:10.2147/CLEP.S53168. https://pubmed.ncbi.nlm.nih.gov/25368531/Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63(4):465-482. doi:10.1002/acr.20460. https://pubmed.ncbi.nlm.nih.gov/21452260/Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.
Episode Notes Books Beardsley, John. Earthworks and Beyond: Contemporary Art in the Landscape. New York: Abbeville Press, 1998. https://archive.org/details/earthworksbeyond0000bear Smithson, Robert. The Collected Writings of Robert Smithson. Edited by Jack Flam. Berkeley: University of California Press, 1996. https://www.ucpress.edu/book/9780520203853/the-collected-writings Holt, Nancy. The Writings of Robert Smithson: Essays with Illustrations. New York University Press, 1979. https://archive.org/details/writingsofrobert0000smit Tufnell, Ben. Land Art. London: Tate Publishing, 2006. https://www.tate.org.uk/art/artists/robert-smithson-1979 Kwon, Miwon. One Place After Another: Site-Specific Art and Locational Identity. Cambridge: MIT Press, 2002. https://mitpress.mit.edu/9780262612029/one-place-after-another Shapiro, Gary. Earthwards: Robert Smithson and Art After Babel. Berkeley: University of California Press, 1997. https://www.ucpress.edu/book/9780520214132/earthwards Journal Articles Boettger, Suzaan. “Global Warnings: Robert Smithson's Spiral Jetty in the Era of Climate Change.” Art Journal 67, no. 2 (2008): 24-45. https://doi.org/10.1080/00043249.2008.10791327 Krauss, Rosalind. "Sculpture in the Expanded Field." October 8 (Spring 1979): 30–44. https://doi.org/10.2307/778224 Roberts, Jennifer L. "The Mirror Displaced: Robert Smithson's 'Spiral Jetty' and the Mirror Travel Works." October 100 (Spring 2002): 21-50. https://www.mitpressjournals.org/doi/10.1162/016228702753711781 Foster, Hal. “The Crux of Minimalism.” October 30 (Fall 1984): 31-46. https://doi.org/10.2307/778357 Strain, Ellen. "Desert Sites: 'Spiral Jetty' and the Cultural Construction of an American Wilderness." The Yale Journal of Criticism 12, no. 2 (1999): 257-281. https://muse.jhu.edu/article/13137 Documentary Films and Multimedia Spiral Jetty: The First 50 Years. Directed by George Trimmer. Documentary Educational Resources, 2020. https://www.der.org/spiral-jetty-the-first-50-years/ Holt, Nancy, and Robert Smithson. Spiral Jetty: A Film by Robert Smithson. Electronic Arts Intermix, 1970. https://www.eai.org/titles/spiral-jetty PBS. “Land Art: Robert Smithson and Spiral Jetty.” Art21: Art in the 21st Century. PBS, 2001. https://art21.org/watch/spiral-jetty/ Exhibition Catalogs Whitney Museum of American Art. Robert Smithson: Retrospective Works 1955-1973. New York: Whitney Museum, 1985. https://whitney.org/exhibitions/robert-smithson Dia Art Foundation. Robert Smithson: Spiral Jetty and Other Works. New York: Dia Art Foundation, 2004. https://www.diaart.org/exhibition/exhibitions-projects/robert-smithson Online Resources and Archives Dia Art Foundation. "Spiral Jetty." Accessed October 25, 2024. https://www.diaart.org/visit/visit/robert-smithson-spiral-jetty Utah Museum of Fine Arts. “Robert Smithson's Spiral Jetty: A Guide.” Last modified 2020. https://umfa.utah.edu/spiral-jetty Holt/Smithson Foundation. “Spiral Jetty: A Legacy.” Accessed October 25, 2024. https://holtsmithsonfoundation.org/spiral-jetty Find out more at https://three-minute-modernist.pinecast.co
During the RNC and DNC, Jen interviewed nine members of Congress about Congress itself. What is it like to work there? Do they think Congress is dysfunctional? If so, how do they think it could be fixed? In this episode, listen to the most interesting responses from all of the interviews. Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via Support Congressional Dish via (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: Please make checks payable to Congressional Dish Thank you for supporting truly independent media! Background Sources David Daley. October 4, 2024. The Guardian. OpenSecrets. OpenSecrets. Accessed October 30, 2024. Congressional Research Service. Accessed October 30, 2024. Congressional Research Service. Music by Editing Production Assistance
This election has featured a lot of talk about ‘immigration' and ‘the border' but has been short on specifics. In this episode, you'll get those specifics. Specifically, you'll learn what was in H.R. 2, a Republican bill passed by the House, and you'll learn what was in the so-called bipartisan border bill which was killed by Donald Trump's loyalists in the Senate and which Kamala Harris has promised to revive as President. Which bill would actually solve the problems? Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via Support Congressional Dish via (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: Please make checks payable to Congressional Dish Thank you for supporting truly independent media! Background Sources Recommended Congressional Dish Episodes Current Immigration Process Visas Accessed October 22, 2024. U.S. Department of State, Bureau of Consular Affairs. Accessed October 22, 2024. Boundless. Accessed October 22, 2024. Boundless. October 22, 2024. USAGov. September 3, 2024. U.S. Department of State, Bureau of Consular Affairs. Asylum August 1, 2024. USAFacts. Ted Hesson and Mica Rosenberg. June 5, 2024. Reuters. Accessed October 22, 2024. Migration Policy Institute. Unauthorized Immigration John Gramlich. October 1, 2024. Pew Research Center. Jeffrey S. Passel and Jens Manuel Krogstad. July 22, 2024. Pew Research Center. Backlog December 18, 2023. TRAC Immigration. Immigrant Detention Eunice Cho. August 7, 2023. American Civil Liberties Union. Irwin County Detention Center November 15, 2022. Senate Committee on Homeland Security and Governmental Affairs, Permanent Subcommittee on Investigations. Jonathan Raymond. November 15, 2022. 11 ALIVE. May 20, 2021. WABE. Molly O'Toole. May 20, 2021. The LA Times. C. Carlos Carreiro Immigration Detention Center in Bristol County, MA Ben Berke. May 21, 2021. The Public's Radio. December 15, 2020. Office of the Massachusetts Attorney General Civil Rights Division. Etowah County Detention Center in Gadsden, Alabama Erin Wise. April 15, 2022. ABC 33 40 News. Ted Hesson and Mica Rosenberg. March 25, 2022. Reuters. March 25, 2022. BirminghamWatch. March 25, 2022. U.S. Immigration and Customs Enforcement. Paul Moses. June 8, 2018. The Daily Beast. Glades County Detention Center in Moore Haven, Florida February 2, 2022. Freedom for Immigrants. Debbie Wasserman Schultz et al. February 1, 2022. South Texas Family Residential Center Accessed October 22, 2024. OpenSecrets. Sandra Sanchez. Updated June 24, 2024. Border Report. Ted Hesson. June 10, 2024. Reuters. Penalties for Illegally Entering Countries World Population Review. Bipartisan Border Bill Failure Ariana Figueroa. May 24, 2024. Missouri Independent. Catherine Rampell. May 23, 2024. The Washington Post. Mary Clare Jalonick and Stephen Groves. February 7, 2024. AP News. Mary Clare Jalonick and Stephen Groves. February 7, 2024. AP News. The Bills H.R. 2 Outline Division A - Border Wall Would require the Secretary of Homeland Security to resume “all activities” related to constructing a border wall between the US and Mexico that were planned by the Trump administration. Wall would have to be at least 900 miles long, and include not only a physical wall, but also surveillance towers, radars, seismic acoustic detection sensors, and 24 hour drone monitoring. Would require killing all carrizo cane and salt cedar plants along the Rio Grande River by releasing non-stinging wasps imported from Spain and France into the area. Would waive “all legal requirements” that would stand in the way of of building the wall. Division B - Immigration Enforcement and Foreign Affairs Would make it illegal to process asylum claims of individuals who: do not enter at official ports of entry. crossed through another country on their way to the US and did not apply to live there and receive an official denial in each country they entered before entering the US. have been convicted of misdemeanor offenses, allowing the Secretary of Homeland Security or Attorney General to add disqualifying acts without approval from Congress and no court reviews allowed. Would allow the Secretary of Homeland Security to take away the authorization for an individual who has been accepted into the US through the asylum process to work legally in the US. Work permits would only be authorized for 6 months at a time. Would reopen detention centers that were closed by the Biden Administration. Title V - Protection of Children Would require the DHS Secretary to return unaccompanied children back to their home countries if they are not trafficking victims and do not have a fear of Return. Would authorize immigration officers to withdraw a child's application to be admitted into the United States regardless of the child's ability or desire to do so. Would require the DHS to collect information - name, social security number, DOB, address, contact info, and immigration status - of people who will be taking custody of immigrant children. Within 30 days of receiving that information, if they determine that individual is not legally in the United States, must initiate removal proceedings. Would change the law so that these people have “access” to lawyers instead of having lawyers to represent them. Title VI - Visa Overstay Penalties Would Increase fines for illegally entering the United States from $50-250 to $500-1000 Would create new penalties for overstaying visas: First offense: fines up to $1,000 or up to 6 months in prison, or both Repeat offenses: fines up to $2,000 or up to 2 years in prison, or both S.4361 Outline Division A - Border Security & Combatting Fentanyl Supplemental Appropriations $6.3 billion to border patrol. $6 billion to Immigration and Customs Enforcement. ~$2.4 billion for deportations. ~$1.6 billion for prisons (the goal in the bill is for ICE to be able to detain 46,500 humans at all times). ~$1.2 billion for services to help people navigate the immigration and asylum system, and to help people leave the country if denied visas (). ~$415 million to hire more ICE agents (goal is to hire 800 more agents). ~$200 million for counter fentanyl investigations. ~$4 billion to US Citizenship and Immigration Services with most going towards hiring more staff. ~ $1.2 billion to the State Department $850 million for “humanitarian needs in the Western Hemisphere” to reduce migration (with the idea being that if their home countries are less dangerous, then people won't want to come here as often) $230 million to pay other countries to accept deported individuals. $440 million, most of which would be spent on Immigration Judge Teams which include lawyers, court administrators, staff, and court costs. Would expand the number of border patrol and ICE officers authorized to issue a notice to appear, reducing the workload of the judges. Would allow protection determination proceedings to take place in any federally owned or leased building that is not property owned, leased or managed by ICE or border patrol and is “a reasonable distance” from the migrants current residence, expanding the locations where the cases can be heard beyond the already too crowded court buildings. Division B - Border Act Title I - Capacity Building For five years: would give the Secretary of Homeland Security the authority to appoint people to positions within the Refugee, Asylum, and International Operation Directorate, the Field Operations Directorate, and the Service Center Operations Directorate of US Citizenship and Immigration Services if the Secretary determines that a critical hiring need exists. would give the Secretary of Homeland Security the authority to appoint ICE deportation officers if the Secretary determines that a critical hiring need exists. Would provide a permanent authority for the DHS Secretary to re-hire a former employee to any position in ICE, Border Patrol, or US Citizenship & Immigration Services. Would give asylum officers a 15% pay raise. Would require annual training for border patrol officers about the law, de- escalation techniques, and migrant and agent safety measures. Title III - Securing America For three years, the Secretary of Homeland Security would be given the authority “in the Secretary's sole and unreviewable discretion” to declare a “border emergency” and remove any migrant who doesn't have pre-determined permission to enter the United States or doesn't present themselves at a port of entry in accordance with a process approved by the DHS Secretary. Title IV - Promoting Legal Immigration Would set up a special process to more easily admit no more than 10,000 refugees who worked with the United States from Afghanistan. Would allow the spouse, fiancé, or child of an admitted migrant to join them in the United States and receive employment authorizations. Would slightly increase the number of visas for family members that would be issued in years 2025 through 2029 (512,000 instead of 480,000 = ~ 6% increase). Audio Sources August 22, 2024 29:45 Vice President Kamala Harris: And let me be clear. After decades in law enforcement, I know the importance of safety and security, especially at our border. Last year, Joe and I brought together Democrats and conservative Republicans to write the strongest border bill in decades. The Border Patrol endorsed it. But Donald Trump believes a border deal would hurt his campaign. So he ordered his allies in Congress to kill the deal. Well, I refuse to play politics with our security. Here is my pledge to you: As President, I will bring back the bipartisan border security bill that he killed. And I will sign it into law. July 18, 2024 April 18, 2018 Senate Judiciary Committee, Subcommittee on Border Security and Immigration Witness: James McHenry, Director, Executive Office for Immigration Review, U.S. Department of Justice Clips 2:42 Sen. John Cornyn (R-TX): Earlier administrations, both Republican and Democrat, have struggled with how to reduce the case backlogs in the immigration courts. And, unfortunately, Congress has never provided the full extent of immigration judges and support staff truly needed to eliminate the backlogs. As a result, backlogs continue to grow, from 129,000 cases in fiscal 1998 to a staggering 684,000 as of February 2018. 3:27 Sen. John Cornyn (R-TX): Aliens in removal proceedings sometimes wait for years before they ever appear before an immigration judge. For example, as of February 2018 courts in Colorado have the longest time for cases sitting on their docket more than 1,000 days -- almost three years. In my home state of Texas, the current wait is 884 days -- almost two and a half years. 28:45 James McHenry: A typical immigration court proceeding has two stages, or two parts. The first is the determination of removability. The Department of Homeland Security brings charges and allegations that an alien has violated the immigration laws. The judge, the immigration judge, first has to determine whether that charge is sustained, and that will be based on the factual allegations that are brought, so the judge will make determinations on that. If there is a finding that the alien is removable, then the case proceeds to a second phase. If the judge finds the alien is not removable, then the case is terminated. At the second phase, the immigration judge gives the alien an opportunity to apply for any protection or relief from removal that he or she may be eligible for under the Immigration and Nationality Act. This will involve the setting of a separate hearing at which the respondent may present evidence, they may present witnesses, they have the right to cross-examine witnesses brought by the department, and they will bring up whatever factual bases there is for their claim of relief or protection. At the end of that hearing, the immigration judge will assess the evidence, will assess the testimony, will look at the law, and will render a decision. The judge may either grant the application, in which case the respondent will get to remain in the United States. The judge may deny the application but give the respondent an opportunity to voluntarily depart at their own expense and sometimes after paying a bond, or the immigration judge may order the alien removed. 41:50 Senator Mike Lee (R-UT): I believe you recently testified in front of the House Judiciary Committee that it would take about 700 immigration judges in order to be able to address the backlog and address the current case load. Is that correct? James McHenry: Yeah, last fall the president proposed adding additional immigration judges, up to a number of 700. If we can get 700 on board, especially with our performance measures, we could complete over 450,000 cases a year. That would eviscerate the backlog. Sen. Mike Lee (R-UT): So, 700 would do it…. End of Episode Announcements Andrew Heaton's New Book: Music by Editing Production Assistance
In a special co-branded episode between Oncology On the Go hosted by CancerNetwork® and the American Society for Transplantation and Cellular Therapy (ASTCT)'s program ASTCT Talks, Alexis K. Kuhn, PharmD, BCOP, spoke with Katie Bruce, PharmD, BCPPS, and Susie Long, PharmD, about the use of approved cell-based gene therapies for patients with sickle cell disease, beta thalassemia, adrenoleukodystrophy (ALD), and metachromatic leukodystrophy (MLD). These panelists shared the pharmacist's perspective on ensuring quality care with these ex vivo gene therapies across all treatment phases, including mobilization, conditioning, and infection prophylaxis. Kuhn is an ambulatory Pediatric Hematology/Oncology/BMT Pharmacist at the Mayo Clinic in Rochester, Minnesota, and an assistant professor of Pharmacy at the Mayo Clinic College of Medicine. Bruce is a pediatric clinical pharmacy specialist at the Sarah Cannon Pediatric Hematology/Oncology & Cellular Therapy program of Tristar Centennial Medical Center in Nashville, Tennessee. Long is a pediatric clinical pharmacist in the Blood and Marrow Team at the University of Minnesota Masonic Children's Hospital. Specifically, the panelists spoke about the use of agents like elivaldogene autotemcel (Skysona) and atidarsagene autotemcel (Lenmeldy), which are FDA-approved for ALD and MLD, respectively. They also discussed the use of exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia), which the FDA approved for treating patients 12 years and older with sickle cell disease in December 2023. The conversation broke down each stage of treatment, detailing optimal strategies for the cell manufacturing and storing processes as well as the management of toxicities like cytopenias. They also reviewed key considerations during the post-infusion period that may help maximize the quality of life for patients after they complete their therapy. “It has been so amazing to be able to be a part of gene therapy and gene editing,” Bruce stated regarding the potential long-term impacts of these treatments. “We have patients who are able to hold full-time jobs they never were able to have before. We have patients who are climbing mountains and backpacking through Europe, which would have never been an option before because their sickle cell disease would have prevented them from [doing] that…. It's not an easy process, and it has a lot of steps for the patient to go through, but the reward at the end of it all is worth it.” References 1. bluebird bio receives FDA accelerated approval for SKYSONA® gene therapy for early, active cerebral adrenoleukodystrophy (CALD). News release. bluebird bio, Inc. September 16, 2022. Accessed October 7, 2024.https://tinyurl.com/mp8crxes 2. FDA approves first gene therapy for children with metachomatic leukodystrophy. New release. FDA. March 18, 2024. Accessed October 7, 2024. https://tinyurl.com/mrh659yk 3. FDA approves first gene therapies to treat patients with sickle cell disease. News release. FDA. December 8, 2023. Accessed October 7, 2024. https://tinyurl.com/3zbdnf4c
In a special co-branded episode between Oncology On the Go hosted by CancerNetwork® and the American Society for Transplantation and Cellular Therapy (ASTCT)'s program ASTCT Talks, Alexis K. Kuhn, PharmD, BCOP, spoke with Katie Bruce, PharmD, BCPPS, and Susie Long, PharmD, about the use of approved cell-based gene therapies for patients with sickle cell disease, beta thalassemia, adrenoleukodystrophy (ALD), and metachromatic leukodystrophy (MLD). These panelists shared the pharmacist's perspective on ensuring quality care with these ex vivo gene therapies across all treatment phases, including mobilization, conditioning, and infection prophylaxis. Kuhn is an ambulatory Pediatric Hematology/Oncology/BMT Pharmacist at the Mayo Clinic in Rochester, Minnesota, and an assistant professor of Pharmacy at the Mayo Clinic College of Medicine. Bruce is a pediatric clinical pharmacy specialist at the Sarah Cannon Pediatric Hematology/Oncology & Cellular Therapy program of Tristar Centennial Medical Center in Nashville, Tennessee. Long is a pediatric clinical pharmacist in the Blood and Marrow Team at the University of Minnesota Masonic Children's Hospital. Specifically, the panelists spoke about the use of agents like elivaldogene autotemcel (Skysona) and atidarsagene autotemcel (Lenmeldy), which are FDA-approved for ALD and MLD, respectively. They also discussed the use of exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia), which the FDA approved for treating patients 12 years and older with sickle cell disease in December 2023. The conversation broke down each stage of treatment, detailing optimal strategies for the cell manufacturing and storing processes as well as the management of toxicities like cytopenias. They also reviewed key considerations during the post-infusion period that may help maximize the quality of life for patients after they complete their therapy. “It has been so amazing to be able to be a part of gene therapy and gene editing,” Bruce stated regarding the potential long-term impacts of these treatments. “We have patients who are able to hold full-time jobs they never were able to have before. We have patients who are climbing mountains and backpacking through Europe, which would have never been an option before because their sickle cell disease would have prevented them from [doing] that…. It's not an easy process, and it has a lot of steps for the patient to go through, but the reward at the end of it all is worth it.” References bluebird bio receives FDA accelerated approval for SKYSONA® gene therapy for early, active cerebral adrenoleukodystrophy (CALD). News release. bluebird bio, Inc. September 16, 2022. Accessed October 7, 2024. https://tinyurl.com/mp8crxes FDA approves first gene therapy for children with metachomatic leukodystrophy. New release. FDA. March 18, 2024. Accessed October 7, 2024. https://tinyurl.com/mrh659yk FDA approves first gene therapies to treat patients with sickle cell disease. News release. FDA. December 8, 2023. Accessed October 7, 2024. https://tinyurl.com/3zbdnf4c
This podcast will shed light on the prevalence and significance of post-traumatic stress disorder (PTSD) in the non-veteran population of the United States, with a particular focus on the unique aspects of PTSD in women compared to those in men. References and Resources American Psychiatric Association. What is posttraumatic stress disorder (PTSD)? Accessed October 4, 2024. https://www.psychiatry.org/patients-families/ptsd/what-is-ptsd. Center for Substance Abuse Treatment (US). Trauma-Informed Care in Behavioral Health Services. Substance Abuse and Mental Health Services Administration (US); 2014. (Treatment Improvement Protocol (TIP) Series, No. 57.) Exhibit 1.3-4. https://www.ncbi.nlm.nih.gov/books/NBK207191/box/part1_ch3.box16/ Davis LL, Schein J, Cloutier M, et al. The economic burden of posttraumatic stress disorder in the United States from a societal perspective. J Clin Psychiatry. 2022;83(3):21m14116. doi:10.4088/JCP.21m14116 Husarewycz MN, El-Gabalawy R, Logsetty S, Sareen J. The association between number and type of traumatic life experiences and physical conditions in a nationally representative sample. Gen Hosp Psychiatry. 2014;36(1):26-32. doi: 10.1016/j.genhosppsych.2013.06.003 National Institute of Mental Health. Post-traumatic stress disorder (PTSD). Accessed October 4, 2024. https://www.nimh.nih.gov/health/statistics/post-traumatic-stress-disorder-ptsd Olff M, Willemien L. Why men and women may respond differently to psychological trauma. Psychiatric Times. Accessed October 4, 2024. https://www.psychiatrictimes.com/view/why-men-and-women-may-respond-differently-to-psychological-trauma PTSD: National Center for PTSD. PTSD basics. U.S. Department of Veterans Affairs. Accessed October 4, 2024. https://www.ptsd.va.gov/understand/what/ptsd_basics.asp PTSD: National Center for PTSD. PTSD checklist for DSM-5 (PCL-5). U.S. Department of Veterans Affairs. Accessed October 4, 2024. https://www.ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp Ramos N, Marr MC. Traumatic stress and resilience among transgender and gender diverse youth. Child Adolesc Psychiatr Clin N Am. 2023;32(4):667-682. doi:10.1016/j.chc.2023.04.001 Tobin-Tyler E, Dickman SL. Rape, homicide, and abortion bans—the abandonment of people subjected to sexual and intimate partner violence. N Engl J Med. 2024;391(4):289-292. doi:10.1056/NEJMp2405254 Vogt D. Research on women, trauma, and PTSD. U.S. Department of Veterans Affairs. Accessed October 4, 2024. https://www.ptsd.va.gov/professional/treat/specific/ptsd_research_women.asp Wang Y, Chung MC, Wang N, Yu X, Kenardy J. Social support and posttraumatic stress disorder: a meta-analysis of longitudinal studies. Clin Psychol Rev. 2021;85:101998. doi.org/10.1016/j.cpr.2021.101998 World Health Organization. Post-traumatic stress disorder. Accessed October 4, 2024. https://www.who.int/news-room/fact-sheets/detail/post-traumatic-stress-disorder
Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives
On September 17, 2024, Ascensia Diabetes Care and Senseonics announced the US Food and Drug Administration's (FDA) clearance of the Eversense 365 system for people with type 1 and type 2 diabetes aged 18 years or older—the world's first 1-year continuous glucose monitor (CGM). A fully implantable, long-term CGM option, the Eversense 365 offers a 12-month sensor survivability and implantable sensor, which allow for fewer data interruptions, less waste, and lessened burden on quality of life, according to the release from Ascensia and Senseonics. Other features highlighted by the companies include a silicone-based adhesive that can be changed daily, a removable transmitter that can be taken on and off without wasting a sensor or adding a warmup period, and on-body vibration alerts to keep patients notified when away from their phone. Ascensia and Senseonics also pointed out Eversense 365 had been cleared as an integrated CGM system, which allows for integration with compatible medical devices, including insulin pumps as part of an automated insulin delivery system. “Managing diabetes can be stressful and it is important for technology to disrupt life as little as possible to limit this burden,” said Brian Hansen, president of CGM at Ascensia Diabetes Care, a subsidiary of PHC Holdings Corporation (TSE 6523). “Eversense 365 allows people with diabetes to focus on living their lives, rather than managing the limitations that many experience with short-term CGMs. We are very excited about Senseonics' ability to once again bring true innovation to the CGM space and are working closely with our partner to make Eversense 365 commercially available as soon as possible.” In this special edition of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, Hansen joins hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, for a deep dive into the Eversense 365 and what clearance means for people with diabetes. During the episode, key points of discussion include the product's features like reduced calibrations, the convenience of the transmitter's USB charging, and its suitability for active patients. During the discussion, Hansen emphasizes the role of patient choice in design and future direction for Eversense. Hansen notes Eversense is currently working to expand inserter networks and pursue pump partnerships, with future goals to include a fully implantable sensor without a transmitter. Relevant disclosures for Isaacs include Eli Lilly and Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and others. Relevant disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and others. References: Campbell P. FDA clears Eversense 365, marking First 1-year CGM option in diabetes. HCP Live. September 18, 2024. Accessed October 15, 2024. https://www.hcplive.com/view/fda-clears-eversense-365-marking-first-1-year-cgm-option-in-diabetes. Senseonics. Eversense 365 receives FDA Clearance: The World's first one year CGM. Senseonics. September 17, 2024. Accessed October 15, 2024. https://www.senseonics.com/investor-relations/news-releases/2024/09-17-2024-120118174. Key Timestamps and Highlights 00:00 - Introduction and Guest Introduction 02:04 - Overview of Eversense 365 07:20 - Details on the Transmitter 08:44 - Patient Candidate and Use Cases 13:55 - Medicare Coverage and Integration with Insulin Pumps 17:01 - Future Goals and Patient Choice 28:38 - App and Remote Patient Monitoring
In which I talk about Anglican theologian Jeremy Taylor and Puritan theologian Jonathan Edwards. Taylor emphasizes the 'nowness' of the Eucharist by describing it as a copy of Christ's re-presentation of his sacrifice in heaven. Edwards emphasizes the 'not-yet-ness' of the Eucharist by describing it as a foretaste of the marriage supper of the Lamb. References in my paper: Anglican Church in North America. The Book of Common Prayer. Huntington Beach, CA: Anglican Liturgy Press, 2019. Danaher Jr., William J. “By Sensible Signs Represented: Jonathan Edwards' Sermons on the Lord's Supper.” Pro Ecclesia 7, no. 3 (August 1998). Accessed October 20, 2023. Atla Religion Database. Edwards, Jonathan. “Sermon Notes on 1 Corinthians 1:9.” 1729. Sermons, Series II. WJE Online Vol. 44. Jonathan Edwards Center, Yale University, New Haven, CT. ———. “Sermon Notes on 1 Corinthians 11:29.” January 1733. Sermons, Series II. WJE Online Vol. 48. Jonathan Edwards Center, Yale University, New Haven, CT. ———. “Sermon Notes on Luke 22:30.” June 1733. Sermons, Series II. WJE Online Vol. 48. Jonathan Edwards Center, Yale University, New Haven, CT. McAdoo, H. R. The Eucharistic Theology of Jeremy Taylor Today. Norwich, UK: The Canterbury Press Norwich, 1988. McAdoo, H.R. and Kenneth W. Stevenson. The Mystery of the Eucharist in the Anglican Tradition. Norwich, UK: The Canterbury Press Norwich, 1997. McClymond, Michael J. and Gerald R. McDermott. The Theology of Jonathan Edwards. New York: Oxford University Press, 2012. Taylor, Jeremy. “The Worthy Communicant.” In Jeremy Taylor: Selected Works. Edited by Thomas K. Carroll. Mahwah, NJ: Paulist Press, 1990. Beneath The Willow Tree is a podcast dedicated to the pursuit of Truth through wisdom and imagination. Join host Sophie Burkhardt as she, fuelled by wonder and a quest for the beautiful, explores philosophy, theology, the arts and all things worthy of thought beneath the willow tree. If you might ever be interested in talking about any such things, or a specific book or movie, etc. please reach out to me at sdburkhardt321@gmail.com!
Deep in the woods near Cornwall, Connecticut, in a valley known as the Dark Entry Forest, lie the remains of the small village of Dudleytown. Settled in the mid-eighteenth century by British colonists, Dudleytown was a thriving mining community that for provided charcoal and other minerals for the growing steel industry in and around New England. But by the late nineteenth century, the mining industry had shifted west and slowly, but surely the population of Dudleytown shrank until there, by the early twentieth century, there were only a handful of people living in the village. By 1924, the village of Dudleytown was completely abandoned and fell into the ownership of a private trust, who sought to restore the forest ecosystem to its pre-colonial health.In retrospect, historians and others familiar with the region have cited a variety of social, economic, and ecological reasons for the collapse and abandonment of Dudleytown, yet there are those who believe the abandonment of the village has a darker and more supernatural explanation. There were rumors of widespread madness among the villagers, unexplained deaths and other tragedies, and a curse that dates back to the founding of village in the 1740s.Today, the area is said to be haunted and, despitebeing private property, it has become a popular destination for ghost hunters and legend trippers who are determined to find out whether Dudleytown is truly a cursed village or just a victim of shifting social and economic trends.Thank you to the incredible Dave White of Bring me the Axe Podcast for Research!ReferencesBarlow, Bart. 1980. "A lost town populated by legends." New York Times, October 26: C2.Campos, Chris. 1976. "The death of a town is the life of a curse." The Journal, May 29: 1.Cornwall Conservation Commission. 2012. The Land and People of Cornwall, Connecticut: A Conservation Perspective of Our Town's Natural Treasures. Historical evalutation, Cornwall, CT: Cornwall Conservation Commission.Cornwall Historical Society. 2014. The Truth about Dudleytown. September 29. Accessed October 29,2023. http://cornwallhistoricalsociety.blogspot.com/2014/09/the-truth-about-dudleytown.html.Drozdowski, Ted. 1978. "Old ghouls still haunt state's cliffs, villages." The Morning Record and Journal,October 28: 35.Hartford Courant. 2006. "True curse haunting family's forest land was progress." Hartford Courant,October 25: B2.Hutter, David. 2008. Man pays price to spot Dudleytown ghosts. August 3. Accessed October 3, 2023.https://www.registercitizen.com/news/article/Man-pays-price-to-spot-Dudleytown-ghosts-12147138.php.New England Historical Society. n.d. The Dudleytown Curse, Connecticut's Village of the Damned.Accessed October 3, 2023. https://newenglandhistoricalsociety.com/the-dudleytown-curse-connecticuts-village-of-the-damned/.Pallatto, John. 1980. "Only the ghost hunters walk in legend-cursed Dudleytown." Hartford Courant,November 1: 9.Pettit, John. 1996. "The spirits were willing, but the flesh was weak." Record Journal, October 31: 1.Revai, Cheri. 2006. Haunted Connecticut: Ghosts and Strange Phenomena of the Constitution State.Mechanicsburg, PA: Stackpole Books.Rierden, Andi. 1989. "A hamlet that can't get rid of its ghosts." New York Times, October 29: C2.Ryan, Bill. 1986. "Dudleytown legend haunts Cornwall." Hartford Courant, April 13: 12.Siedzik, Jason. 2011. In Cornwall, Dudleytown movie makers arrested. December 8. Accessed October 3,2023. https://www.ctinsider.com/news/article/In-Cornwall-Dudley-Town-Movie-Makers-Arrested-16886230.php.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
PainExam Podcast Show Notes: Exploring Traumeel as an Alternative for Back Pain Relief Claim CME The CE experience for this Podcast is powered by CMEfy - click here to reflect and earn credits: https://earnc.me/HoEWFd Board Prep and Continuing Education Introduction: Today, Long Island Based Pain Physician David Rosenblum, MD delves into the latest advancements and alternative treatments for pain management. In today's episode, we shine a spotlight on Traumeel®, a homeopathic alternative gaining traction for its anti-inflammatory properties, with fewer reported side effects compared to corticosteroids. Understanding Traumeel: Traumeel, a fixed combination of diluted plant and mineral extracts, has been available over-the-counter in Europe for over 60 years. Contrary to corticosteroids, Traumeel's popularity has surged due to its limited side effect profile, with reported contraindications primarily linked to allergies [9]. View Full Calendar Scientific Insights: A study by Lussignoli et al. demonstrated Traumeel's efficacy in decreasing systemic interleukin-6 production and reducing edema, countering an unregulated inflammatory response [10]. In vitro studies revealed Traumeel's inhibition of pro-inflammatory mediators (IL-1β, TNFα, IL-8) in immune cells, suggesting its potential in stabilizing the immune system [8]. Notably, Traumeel's effectiveness seems to surpass the sum of its individual components, indicating a synergistic interaction [9-10]. Clinical Applications: Traumeel has shown efficacy comparable to nonsteroidal anti-inflammatory drugs (NSAIDs) in treating various inflammatory conditions. It is available in oral, topical, and injectable preparations, making it a versatile option for pain relief [8-9]. Research Gaps and Potential: Despite its established use, current research lacks information on Traumeel's efficacy in epidural injections for short-term back pain relief. No studies have compared Traumeel to corticosteroid injections, although the TRARO study protocol proposes a potential avenue for comparison in rotator cuff syndrome patients [11]. Pain Management Board Prep Clinical Cases: Five patients seeking back pain relief opted for Traumeel injections due to either a contraindication to or a preference against steroids. This real-world scenario lays the groundwork for further exploration into Traumeel's efficacy in epidural injections, providing additional pain-relieving options for patients unable to tolerate corticosteroid injections. Conclusion: Traumeel presents a promising alternative for pain management, particularly in cases where corticosteroids may be unsuitable, however the FDA has yet to approve it and therefore it has failed to gain traction in the US. [14] As we wrap up, stay tuned for future developments in the research landscape surrounding Traumeel and its potential role in enhancing pain relief options. Disclaimer: Consult with a healthcare professional before considering any alternative treatments. The information provided in this podcast is for educational purposes only and does not replace medical advice. David Rosenblum, MD President, NRAP Academy Clinical Assistant Professor Department of Anesthesiology SUNY Downstate Medical Center Director of Pain Management Maimonides Medical Center References 1. Cassidy JD, Carroll LJ, Côté P: The Saskatchewan health and back pain survey. The prevalence of low back pain and related disability in Saskatchewan adults. Spine (Phila Pa 1976). 1998, 23:1860-66. 10.1097/00007632-199809010-00012 2. Rudy TE, Weiner DK, Lieber SJ, Slaboda J, Boston JR: The impact of chronic low back pain on older adults: a comparative study of patients and controls. Pain. 2007, 131:293-301. 10.1016/j.pain.2007.01.012 3. Fyneface-Ogan S: Anatomy and Clinical Importance of the Epidural Space. Epidural Analgesia - Current Views and Approaches. IntechOpen. IntechOpen (ed): IntechOpen, Internet; 2012. 1-14. 10.5772/39091 4. Waldman SD: Complications of cervical epidural nerve blocks with steroids: a prospective study of 790 consecutive blocks. Reg Anesth. 1989, 14:149-51. 5. McGrath JM, Schaefer MP, Malkamaki DM: Incidence and characteristics of complications from epidural steroid injections. Pain Med. 2011, 12:726-31. 10.1111/j.1526-4637.2011.01077.x 6. Watters WC 3rd, Resnick DK, Eck JC, et al.: Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 13: injection therapies, low-back pain, and lumbar fusion. J Neurosurg Spine. 2014, 21:79-90. 10.3171/2014.4.SPINE14281 7. Understanding Potential Complications Of Epidural Steroid Injections . (2011). Accessed: October 1, 2019: https://www.practicalpainmanagement.com/treatments/interventional/injections/understanding-potentialcomplications-ep…. 8. Schneider C: Traumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med. 2011, 4:225-34. 10.2147/IJGM.S16709 9. Grech D, Velagala J, Dembek DJ, Tabaac B: Critical literature review of the homeopathic compound Traumeel for treatment of inflammation. Pharmacology & Pharmacy. 2018, 9:67-83. 10. Lussignoli S, Bertani S, Metelmann H, Bellavite P, Conforti A: Effect of Traumeel S®, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med. 1999, 7:225-30. 10.1016/S0965-2299(99)80006-5 11. Vanden Bossche L, Vanderstraeten G: A multi-center, double-blind, randomized, placebo-controlled trial protocol to assess Traumeel injection vs dexamethasone injection in rotator cuff syndrome: the TRAumeel in ROtator cuff syndrome (TRARO) study protocol. BMC Musculoskelet Disord. 2015, 16:8. 10.1186/s12891- 015-0471-z 12. Birnesser H, Oberbaum M, Klein P, Weiser M: The homeopathic preparation Traumeel® S compared with NSAIDS for symptomatic treatment of epicondylitis 13. Ehlert, Dianna, and Ariel Majjhoo. "Traumeel® Epidural Injection: A Viable Alternative to Corticosteroids-A Five-Patient Case Study." Cureus 11.11 (2019) 14. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medinatura-inc-596269-06112020
PainExam Podcast Show Notes: Exploring Traumeel as an Alternative for Back Pain Relief Claim CME The CE experience for this Podcast is powered by CMEfy - click here to reflect and earn credits: https://earnc.me/HoEWFd Board Prep and Continuing Education Introduction: Today, Long Island Based Pain Physician David Rosenblum, MD delves into the latest advancements and alternative treatments for pain management. In today's episode, we shine a spotlight on Traumeel®, a homeopathic alternative gaining traction for its anti-inflammatory properties, with fewer reported side effects compared to corticosteroids. Understanding Traumeel: Traumeel, a fixed combination of diluted plant and mineral extracts, has been available over-the-counter in Europe for over 60 years. Contrary to corticosteroids, Traumeel's popularity has surged due to its limited side effect profile, with reported contraindications primarily linked to allergies [9]. View Full Calendar Scientific Insights: A study by Lussignoli et al. demonstrated Traumeel's efficacy in decreasing systemic interleukin-6 production and reducing edema, countering an unregulated inflammatory response [10]. In vitro studies revealed Traumeel's inhibition of pro-inflammatory mediators (IL-1β, TNFα, IL-8) in immune cells, suggesting its potential in stabilizing the immune system [8]. Notably, Traumeel's effectiveness seems to surpass the sum of its individual components, indicating a synergistic interaction [9-10]. Clinical Applications: Traumeel has shown efficacy comparable to nonsteroidal anti-inflammatory drugs (NSAIDs) in treating various inflammatory conditions. It is available in oral, topical, and injectable preparations, making it a versatile option for pain relief [8-9]. Research Gaps and Potential: Despite its established use, current research lacks information on Traumeel's efficacy in epidural injections for short-term back pain relief. No studies have compared Traumeel to corticosteroid injections, although the TRARO study protocol proposes a potential avenue for comparison in rotator cuff syndrome patients [11]. Pain Management Board Prep Clinical Cases: Five patients seeking back pain relief opted for Traumeel injections due to either a contraindication to or a preference against steroids. This real-world scenario lays the groundwork for further exploration into Traumeel's efficacy in epidural injections, providing additional pain-relieving options for patients unable to tolerate corticosteroid injections. Conclusion: Traumeel presents a promising alternative for pain management, particularly in cases where corticosteroids may be unsuitable, however the FDA has yet to approve it and therefore it has failed to gain traction in the US. [14] As we wrap up, stay tuned for future developments in the research landscape surrounding Traumeel and its potential role in enhancing pain relief options. Disclaimer: Consult with a healthcare professional before considering any alternative treatments. The information provided in this podcast is for educational purposes only and does not replace medical advice. David Rosenblum, MD President, NRAP Academy Clinical Assistant Professor Department of Anesthesiology SUNY Downstate Medical Center Director of Pain Management Maimonides Medical Center References 1. Cassidy JD, Carroll LJ, Côté P: The Saskatchewan health and back pain survey. The prevalence of low back pain and related disability in Saskatchewan adults. Spine (Phila Pa 1976). 1998, 23:1860-66. 10.1097/00007632-199809010-00012 2. Rudy TE, Weiner DK, Lieber SJ, Slaboda J, Boston JR: The impact of chronic low back pain on older adults: a comparative study of patients and controls. Pain. 2007, 131:293-301. 10.1016/j.pain.2007.01.012 3. Fyneface-Ogan S: Anatomy and Clinical Importance of the Epidural Space. Epidural Analgesia - Current Views and Approaches. IntechOpen. IntechOpen (ed): IntechOpen, Internet; 2012. 1-14. 10.5772/39091 4. Waldman SD: Complications of cervical epidural nerve blocks with steroids: a prospective study of 790 consecutive blocks. Reg Anesth. 1989, 14:149-51. 5. McGrath JM, Schaefer MP, Malkamaki DM: Incidence and characteristics of complications from epidural steroid injections. Pain Med. 2011, 12:726-31. 10.1111/j.1526-4637.2011.01077.x 6. Watters WC 3rd, Resnick DK, Eck JC, et al.: Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 13: injection therapies, low-back pain, and lumbar fusion. J Neurosurg Spine. 2014, 21:79-90. 10.3171/2014.4.SPINE14281 7. Understanding Potential Complications Of Epidural Steroid Injections . (2011). Accessed: October 1, 2019: https://www.practicalpainmanagement.com/treatments/interventional/injections/understanding-potentialcomplications-ep…. 8. Schneider C: Traumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med. 2011, 4:225-34. 10.2147/IJGM.S16709 9. Grech D, Velagala J, Dembek DJ, Tabaac B: Critical literature review of the homeopathic compound Traumeel for treatment of inflammation. Pharmacology & Pharmacy. 2018, 9:67-83. 10. Lussignoli S, Bertani S, Metelmann H, Bellavite P, Conforti A: Effect of Traumeel S®, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med. 1999, 7:225-30. 10.1016/S0965-2299(99)80006-5 11. Vanden Bossche L, Vanderstraeten G: A multi-center, double-blind, randomized, placebo-controlled trial protocol to assess Traumeel injection vs dexamethasone injection in rotator cuff syndrome: the TRAumeel in ROtator cuff syndrome (TRARO) study protocol. BMC Musculoskelet Disord. 2015, 16:8. 10.1186/s12891- 015-0471-z 12. Birnesser H, Oberbaum M, Klein P, Weiser M: The homeopathic preparation Traumeel® S compared with NSAIDS for symptomatic treatment of epicondylitis 13. Ehlert, Dianna, and Ariel Majjhoo. "Traumeel® Epidural Injection: A Viable Alternative to Corticosteroids-A Five-Patient Case Study." Cureus 11.11 (2019) 14. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medinatura-inc-596269-06112020
Can you believe it? I'm finally releasing a new episode! It's a miracle! In this new episode, I'm going to tell you about something that happened on August 22, 1911--something that shocked the world. On that day, the famous Mona Lisa painting was stolen. I'll tell you a little bit about that event, and then share three fun, Additional History stories, too. Enjoy! SOURCES “Advertisement: Kellogg's Cornflakes (Page 3).” Argus-Leader (Sioux Falls, South Dakota), August 22, 1911. www.newspapers.com. Barnebys. “The Incredible 1911 Theft of the Mona Lisa: Barnebys Magazine.” Barnebys.com, July 22, 2022. https://www.barnebys.com/blog/the-incredible-1911-theft-of-the-mona-lisa. “Great Painting Stolen.” Boston Evening Transcript (Boston, Massachusetts), August 22, 1911. www.newspapers.com. “Preacher Accused of Murder.” The Baltimore Sun (Baltimore, Maryland) , January 14, 1909. www.newspapers.com. Sperling, Susan. “Ernest Lyons.” National registry of exonerations pre 1989. Accessed October 18, 2023. https://www.law.umich.edu/special/exoneration/Pages/casedetailpre1989.aspx?caseid=204. Staff, NPR. “The Theft That Made the ‘Mona Lisa' A Masterpiece.” NPR, July 30, 2011. https://www.npr.org/2011/07/30/138800110/the-theft-that-made-the-mona-lisa-a-masterpiece. “Studies in Scarlet.” Curiosity Collections - Harvard Library. Accessed October 18, 2023. https://curiosity.lib.harvard.edu/scarlet. “Widow Needs Help.” The Evening Star (Washington D. C.), August 22, 1911. www.newspapers.com. “Woman and Children Stranded In Station.” Alexandria Gazette (Alexandria, Virginia), August 22, 1911. www.newspapers.com. “‘Murdered Man' Alive, Alleged Slayer In Pen.” The Lawton Daily News (Lawton, Oklahoma), August 22, 1911. www.newspapers.com. SOUND SOURCES Al Jolson. “I'll Say She Does.” www.pixabay.com/music. Lucille Hegamin and The Dixie Daisies. “Cold Winter Blues.” www.pixabay.com/music. Sophie Tucker. “Reuben Rag.” www.pixabay.com/music.
Discovered in Utah County in 1960, Nutty Putty Cave quickly became a popular destination for amateur and professional cavers and spelunkers as a kind of bucket list cave of considerable difficulty. Despite its popularity, beginning in the late 1980s, the cave became notorious for the number of explorers who became trapped and required emergency assistance to escape its twisting, narrow, and poorly mapped passageways.In late November 2009, the inherent risk and dangers of Nutty Putty Cave made national news when twenty-six-year-old college student John Edward Jones became trapped upside-down in an uncharted and perilously narrow section of the cave. Thank you to the incredible Dave White of Bring me the Axe Podcast for research assistance!ReferencesAshton, Katie. 2006. "Nutty Putty Cave entrance getting a gate." Daily Herald, May 2: 23.Associated Press. 2006. "Utah's caves remain open one year after Provo tragedy." Daily Herald, August 14: 8.—. 2009. Man dies after day trapped upside-down in cave. November 25. Accessed October 12, 2023. https://www.nbcnews.com/id/wbna34157005.—. 2009. Man dies after day trapped upside-down in cave. November 25. Accessed October 13, 2023. https://www.nbcnews.com/id/wbna34157005.—. 2009. "Recovery of caver's body deemed too dangerous." Roanoke Times, November 28: 4.—. 2004. "Teen stuck in cave is rescued." Salt Lake Tribune, August 22: 20.Cabero, Alex. 2009. Nutty Putty Cave discoverer doesn't want it to be closed. November 27. Accessed October 12, 2023. https://www.ksl.com/article/8824435/nutty-putty-cave-discoverer-doesnt-want-it-to-be-closed.Canham, Matt. 2004. "BYU student freed from cave." Salt Lake Tribune, Septmber 5: 21.LaPlante, Matthew. 2009. "Popular cave draws ill-prepared adventurers." Salt Lake Tribune, November 25.Nokkentved, N.S. 2005. "State may close popular cave." Daily Herald, June 26: 21.Outside Magazine. 2002. Exploring Caving Accidents, Deaths, and Rescues in the United States. August 3. Accessed October 12, 2023. https://www.outsideonline.com/outdoor-adventure/exploration-survival/exploring-caving-accidents-deaths-and-rescues-united-states/.Peterson, Chris. 2005. "Father says daughter died doing what she loved." Daily Herald, August 19: 1.Reporter-Times. 1999. "Deputies free teens from cave." Reporter-Times, July 29: 3.Tanner, Steve. 1999. "Teens spend long day in dark." Daily Herald, July 29: 1.Waqar, Jehanzeb. 2022. The Nutty Putty Cave and the untimely death of a young caver. December 15. Accessed October 12, 2023. https://interestingengineering.com/culture/nutty-putty-cave-death-young-caver.Whitehurst, Lindsay. 2018. Nutty Putty: ‘I really, really want to get out'. July 9. Accessed October 13, 2023. https://www.sltrib.com/news/2018/07/09/nutty-putty-i-really/.—. 2018. Nutty Putty: ‘We're going to get you out'. July 10. Accessed October 13, 2023. https://www.sltrib.com/news/2018/07/10/nutty-putty-were-going/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this episode, we're covering the recent approval of vamorolone (Agamree; Santhera Pharmaceuticals) oral suspension 40 mg/mL for the treatment of patients with Duchenne muscular dystrophy (DMD) aged 2 years and older. The therapy is set to be acquired by Catalyst Pharmaceuticals soon, and is a first-in-class dissociative steroid that aims to retain the anti-inflammatory activity of corticosteroids while decreasing the deleterious adverse events (AEs). We spoke with Barry J. Byrne, MD, PhD, professor and associate chair of pediatrics and director of the Powell Gene Therapy Center at the University of Florida, who discussed the recent FDA approval of Santhera Pharmaceuticals investigational agent vamorolone (now marketed as Agamree, and soon to be acquired by Catalyst Pharmaceuticals in North America), its potential to affect the treatment paradigm as a first-in-class dissociative steroid, and important efficacy and safety information from the phase 2b VISION-DMD study (NCT03439670). For more of NeurologyLive's coverage of vamorolone's approval, head here: FDA Approves Vamorolone as a Treatment for Duchenne Muscular Dystrophy Episode Breakdown: 0:30 – Vamorolone approved for Duchenne muscular dystrophy 2:20 – Barry J. Byrne, MD, PhD, on his immediate reaction 3:25 – Safety data on vamorolone 4:00 – Byrne on the importance of bone mineralization in DMD 5:10 – Phase 2b efficacy data from VISION-DMD 5:45 – Byrne with context on the efficacy data 7:05 – Byrne with context on the landscape of DMD therapeutic development and personalization approaches Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCES 1. Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals. News release. Catalyst Pharmaceuticals. October 26, 2023. Accessed October 26, 2023. https://www.globenewswire.com/en/news-release/2023/10/26/2767947/13009/en/Catalyst-Pharmaceuticals-Reports-FDA-Approval-of-AGAMREE-vamorolone-for-Duchenne-Muscular-Dystrophy-Granted-to-Santhera-Pharmaceuticals.html 2. Santhera and ReveraGen announce positive and statistically highly significant topline results with vamorolone in pivotal VISION-DMD study. News release. Santhera. June 1, 2021. Accessed February 1, 2023. https://www.globenewswire.com/news-release/2021/06/01/2239124/0/en/Santhera-and-ReveraGen-Announce-Positive-and-Statistically-Highly-Significant-Topline-Results-with-Vamorolone-in-Pivotal-VISION-DMD-Study.html 3. Dang U, Guglieri M, Clemens PR, et al. Delayed start analysis of efficacy outcomes in placebo to vamorolone crossover participants in VBP15-004. Presented at MDA Clinical and Scientific Conference; March 13-16. Poster 89. 4. Muscular Dystrophy Association-Supported Drug AGAMREE® (vamorolone) Approved for the Treatment of Duchenne Muscular Dystrophy by the FDA. News release. MDA. October 26, 2023. Accessed October 26, 2023. https://www.mda.org/press-releases/mda-supported-drug-agamree-vamorolone-approved-for-the-treatment-of-duchenne-muscular-dystrophy-by-the-fda 5. Guglieri M, Clemens PR, Perlman SJ, et al. Efficacy and safety of vamorolone vs placebo and prednisone among boys with Duchenne muscular dystrophy: a randomized clinical trial. JAMA Neurol. Published online August 29, 2022. doi:10.1001/jamaneurol.2022.2480
Welcome to Episode 30 of “The 2 View,” the podcast for EM and urgent care nurse practitioners and physician assistants! Show Notes for Episode 30 of “The 2 View” – oral phenylephrine, visual diagnosis plans, and NSVT. Oral Phenylephrine Myers Z. FDA panel: Many oral allergy meds don't work. WTTV CBS4Indy. Published October 15, 2023. Accessed October 17, 2023. https://cbs4indy.com/news/fda-panel-many-oral-allergy-meds-dont-work/ Neurosyphilis Review Hamill MM, Ghanem KG, Tuddenham S. State of the art review: neurosyphilis. Clin Infect Dis. Published August 18, 2023. Accessed November 1, 2023. doi: 10.1093/cid/ciad437 Visual Diagnosis - Behcet's Disease Behcet's Disease. Vasculitis Foundation. Published July 18, 2012. Accessed October 17, 2023. https://www.vasculitisfoundation.org/education/behcets-disease/ ACEP Clinical Policy on Ischemic Stroke Clinical Policies – Acute Ischemic Stroke. ACEP. Published May 2023. Accessed November 2, 2023. https://www.acep.org/patient-care/clinical-policies/acute-ischemic-stroke The VAN Assessment to Identify Large Vessel Occlusion Strokes. Core EM. Published May 17, 2018. Accessed November 2, 2023. https://coreem.net/journal-reviews/the-van-assessment/ Los Angeles Motor Scale (LAMS). MDCalc. Accessed November 2, 2023. https://www.mdcalc.com/calc/3959/los-angeles-motor-scale-lams Rapid Arterial oCclusion Evaluation (RACE) Scale for Stroke. MDCalc. Accessed November 2, 2023. https://www.mdcalc.com/calc/3941/rapid-arterial-occlusion-evaluation-race-scale-stroke NSVT: Non-Sustained Ventricular Tachycardia Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. Published August 1, 2018. Accessed October 17, 2023. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000549 Farzam K, Tivakaran VS. QT Prolonging Drugs. StatPearls Publishing; 2023. Accessed October 17, 2023. https://www.ncbi.nlm.nih.gov/books/NBK534864/ Foth C, Gangwani MK, Ahmed I, Alvey H. Ventricular Tachycardia. StatPearls Publishing; 2023. Accessed October 17, 2023. https://www.ncbi.nlm.nih.gov/books/NBK532954/ Ep 1 Lady G and Courage Under Fire. Burnt. Published January 27, 2021. Accessed November 2, 2023. https://podcasts.apple.com/us/podcast/ep-1-lady-g-and-courage-under-fire/id1551194920?i=1000506903956 Glaucomflecken. Will and Kristin's Cardiac Arrest Story with Paramedic Lieutenant Aaron Gregg. Published August 22, 2023. Accessed October 17, 2023. https://www.youtube.com/watch?v=CQtYoKPNsrM Laslett DB, Cooper JM, Greenberg RM, et al. Electrolyte Abnormalities in Patients Presenting With Ventricular Arrhythmia (from the LYTE-VT Study). Am J Cardiol. PubMed. NIH: National Library of Medicine: National Center for Biotechnology Information. Published August 15, 2020. Accessed October 17, 2023. https://pubmed.ncbi.nlm.nih.gov/32565090/ Nonsustained ventricular tachycardias. Bmj.com. BMJ Best Practice. Accessed October 25, 2023. https://bestpractice.bmj.com/topics/en-us/831 PVCs and Nonsustained VT: When to Worry? How to Treat? - Penn Physician VideoLink.; 2015. Published January 7, 2015. Accessed October 17, 2023. https://videolink.pennmedicine.org/videos/pvcs-and-nonsustained-vt-when-to-worry-how-to-treat TualatinValleyFire. Dr. Will Flanary - Cardiac Arrest Survivor. Published February 16, 2021. Accessed October 17, 2023. https://www.youtube.com/watch?v=wu9uAwnSrJU Recurring Sources Center for Medical Education. Ccme.org. http://ccme.org The Proceduralist. Theproceduralist.org. http://www.theproceduralist.org The Procedural Pause. Emergency Medicine News. Lww.com. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx The Skeptics Guide to Emergency Medicine. Thesgem.com. http://www.thesgem.com Trivia Question: Send answers to 2viewcast@gmail.com Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to. Be sure to listen in and see what we have to share!
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
In this episode, we will discuss the definition of REMS (Risk Evaluation and Mitigation Strategies), why they exist, the role of FDA in administering REMS, types and examples of REMS, and how they impact pharmacy practice. Key Concepts The REMS (Risk Evaluation and Mitigation Strategies) program was developed in 2007 as part of the FDA's drug risk management strategies designed to balance risk and benefits of certain drugs. Elements of REMS vary depending on the drug, but commonly include medication guides, communication plans, and other elements to assure safe use. REMS can require patients, providers, and pharmacies to take certain actions including training, registration, enrollment, safety monitoring, documentation of safety concerns, and follow prescribing and dispensing regulations. The FDA captures and assesses data on a regular basis to make changes in the REMS program. It also has authority to enforce compliance and take punitive actions against non-compliant parties. References Risk Evaluation and Mitigation Strategies. Food and Drug Administration. May 16, 2023. Accessed October 17, 2023. https://www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems
Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this episode, we're covering the recent approval of zilucoplan (Zilbrysq; UCB Pharma) for the treatment of patients with acetylcholine receptor antibody–positive generalized myasthenia gravis. We spoke with James F. “Chip” Howard, MD, Distinguished Professor of Neuromuscular Disease and professor of neurology and medicine at The University of North Carolina at Chapel Hill School of Medicine, and the lead global investigator of the phase 3 RAISE study (NCT04115293), who discussed the downstream effects of this approval for myasthenia gravis, the available data from clinical studies, and the advantages for patients and physicians. For more of NeurologyLive®'s coverage of zilucoplan's approval, head here: FDA Approves Complement C5 Inhibitor Zilucoplan as Treatment for Myasthenia Gravis Episode Breakdown: 0:30 – Zilucoplan approved for AChR+ myasthenia gravis 1:40 – James F. Howard, MD, on his immediate reaction 3:30 – Safety data from the RAISE trial 4:25 – Howard on the potential advantages of zilucoplan 6:50 – Phase 3 efficacy data for zilucoplan 7:55 – Howard with context on the efficacy and the challenges with therapeutic availability in myasthenia gravis 12:10 – Howard, on the future of therapeutic development Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCES 1. UCB announces US FDA approval of Zilbrysq (zilucoplan) for the treatment of adults with generalized myasthenia gravis. News release. October 17, 2023. Accessed October 17, 2023. https://www.ucb.com/stories-media/Press-Releases/article/UCB-announces-US-FDA-approval-of-ZILBRYSQR-zilucoplan-for-the-treatment-of-adults-with-generalized-myasthenia-gravis 2. Howard JF, Bresch S, Genge A, et al. Safety and efficacy of zilucoplan in patients with generalized myasthia gravis (RAISE): a randomized, double-blind, placebo-controlled, phase 3 study. 2023;22(5):395-406. doi:10.1016/S1474-4422(23)00080-7 3. Genge A, Hussain Y, Kaminski HJ, et al. Safety and tolerability of zilucoplan in RAISE-XT: a multicenter, open-label extension study in patients with myasthenia gravis. Presented at: MDA 2023; February 19-22; Dallas, TX. Abstract 145.
On this week's episode, you will understand your subconscious mind, and your subconscious limiting beliefs, a little better: Where do they come from? Are they serving you? Should you ditch them and go for new ones? As Don Miguel Ruiz would say, humans before us have designed a "dream of the planet", or "society's dream", and we've been raised to believe and perpetuate that belief system... But it might be serving you less than you think. If you want to believe that your dreams are possible, you've come to the right place: whatever your mind believes, you can achieve.RESOURCES:Darnall, B. D. (2010) Mirror Therapy. Expanding global access to phantom pain care. inMotion, Volume 20, Issue 6. Available at: https://www.amputee-coalition.org/resources/mirror-therapy/ (Accessed: October 2023).Ruiz, M (1997; 2018 edition) The Four Agreements: A Practical Guide to Personal Freedom (A Toltec Wisdom Book). Amber-Allen Publishing, Inc.Sincero, J. (2018) You Are A Badass At Making Money. John Murray Publishers Ltd.Swart, T. (2020) The Source: Open Your Mind. Change Your Life. Penguin Random House UK.Follow the show's Instagram here! Follow Inma's Instagram here! Check out the show's website here!
This week I dove a little bit into the different types of darners out there and their Significance in history! I personally like the darning eggs with the short handles, but what are your favorite types of darners? Our Instagram Page Reference List Gilday E. A Darn Good Egg: Darning Tools for Holey Socks. Piecework. 2018;26(1):48-52. Accessed October 16, 2023. https://search-ebscohost-com.ezproxy.snhu.edu/login.aspx?direct=true&db=aft&AN=126584944&site=eds-live&scope=site HABIT F. The Egg and I: Tools for Darning. Piecework. 2020;28(3):12-14. Accessed October 16, 2023. https://search-ebscohost-com.ezproxy.snhu.edu/login.aspx?direct=true&db=edb&AN=144272650&site=eds-live&scope=site https://homethingspast.com/2012/06/07/darning-eggs-mushrooms/
On where success leads.Anonymous (2002). Meditations on the Tarot: A Journey into Christian Hermeticism. New York: Tarcher.Aleister Crowley (1976). The Book of the Law. York Beach, ME: Red Wheel / Weiser.Benjamin Thorpe, translator (2005). The Lay of Grimnir, in: The Elder Eddas of Saemund Sigfusson and the Younger Eddas of Snorre Sturleson, https://tinyurl.com/2pdfbrs2 (gutenberg.org). Accessed October 2023.Support the podcast and access additional content at: https://patreon.com/oeith. Buy me a coffee at https://ko-fi.com/oeith or https://www.buymeacoffee.com/dbarfordG. Or you could send me a lovely book from https://www.amazon.co.uk/hz/wishlist/ls/1IQ3BVWY3L5L5?ref_=wl_share. Hosted on Acast. See acast.com/privacy for more information.
No Christian podcast worth its salt can avoid answering the all-important question: just who were those Nephilim, anyway? After analyzing three theories about the Nephilim in the previous episodes in this series, Chelsea and I present our own theory using ideas from those three. Theories about the Nephilim seem to depend on who were "the sons of God" and "the daughters of men" in Genesis chapter 6. Join us as we present our theory. Sources Consulted: Bullinger's Companion Bible Notes on Numbers 13:3, BibliaPlus.org. Accessed October 8, 2023. "Numbers 13 Commentary," Precept Austin, Updated December 27, 2021. Scriptures Referenced: Luke 17:36-30 Genesis 3:1 Revelation 12:9 Matthew 8:29 Numbers 13:33 *** Castle Rock Women's Health is a pro-life and pro-women health care ministry. They need your help to move into a new office to serve the community better. Please consider a monthly or one-time donation. *** We value your feedback! Have questions for Truthspresso? Contact us!
No Christian podcast worth its salt can avoid answering the all-important question: just who were those Nephilim, anyway?After analyzing three theories about the Nephilim in the previous episodes in this series, Chelsea and I present our own theory using ideas from those three.Theories about the Nephilim seem to depend on who were "the sons of God" and "the daughters of men" in Genesis chapter 6.Join us as we present our theory.Sources Consulted:Bullinger's Companion Bible Notes on Numbers 13:3, BibliaPlus.org. Accessed October 8, 2023."Numbers 13 Commentary," Precept Austin, Updated December 27, 2021.Scriptures Referenced:Luke 17:36-30Genesis 3:1Revelation 12:9Matthew 8:29Numbers 13:33*** Castle Rock Women's Health is a pro-life and pro-women health care ministry. They need your help to move into a new office to serve the community better. Please consider a monthly or one-time donation. ***We value your feedback!Have questions for Truthspresso? Contact us!
No Christian podcast worth its salt can avoid answering the all-important question: just who were those Nephilim, anyway?After analyzing three theories about the Nephilim in the previous episodes in this series, Chelsea and I present our own theory using ideas from those three.Theories about the Nephilim seem to depend on who were "the sons of God" and "the daughters of men" in Genesis chapter 6.Join us as we present our theory.Sources Consulted:Bullinger's Companion Bible Notes on Numbers 13:3, BibliaPlus.org. Accessed October 8, 2023."Numbers 13 Commentary," Precept Austin, Updated December 27, 2021.Scriptures Referenced:Luke 17:36-30Genesis 3:1Revelation 12:9Matthew 8:29Numbers 13:33*** Castle Rock Women's Health is a pro-life and pro-women health care ministry. They need your help to move into a new office to serve the community better. Please consider a monthly or one-time donation. ***We value your feedback!Have questions for Truthspresso? Contact us!
Phenylketonuria (or PKU, for short) is a complex condition to treat, yet nutrition takes center stage. If you need a refresher on the nutrition recommendations, we have you covered. Sara and Lyndel cover the basics you need to know to successfully feed your next patient with PKU. Consider this your PKU crash course. Show Notes: How do health care providers diagnose phenylketonuria (PKU)? NIH website. Updated December 1, 2016. Accessed October 12, 2022: https://bit.ly/2USHOti MacDonald A, van Wegberg AMJ, Ahring K, et al. PKU dietary handbook to accompany PKU guidelines. Orphanet Journal of Rare Diseases. 2020;15:171. Schuck PF, Malgarin F, Cararo JH, et al. Phenylketonuria pathophysiology: on the role of metabolic alterations. Aging and Disease. 2015;6(5):390-399.
Uncomplicated UTIs (Urinary Tract Infections) can have a detrimental impact on emotional wellbeing. Patients may feel ignored by their clinicians, who face a diverse set of challenges when managing uncomplicated UTIs, all of which are important to address when keeping the plan patient-centered. In this podcast, we will discuss patient-clinician communication barriers and the importance of patient[1]centered outcomes in managing uncomplicated UTIs. Disclaimers: This presentation is sponsored by GSK. The speakers are GSK paid healthcare providers. The content is intended to support disease state education and is considered nonpromotional. The content and views expressed therein do not necessarily reflect the views, policies, or position of Pri-Med. This program is limited to Health Care Professionals (HCPs) only. GSK complies with all state and federal laws including transparent reporting and disclosure of payments and transfers of value to HCPs. References: Hilt EE, McKinley K, Pearce MM, et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014;52(3):871-876. doi:10.1128/JCM.02876-13 Lindsay LE, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis 68, no. 10 (May 2, 2019): e83–110. https://doi.org/10.1093/cid/ciy1121 Advani SD, Polage CR, Fakih MG. Deconstructing the urinalysis: A novel approach to diagnostic and antimicrobial stewardship. Antimicrob Steward Healthc Epidemiol. 2021;1(1):e6. doi: 10.1017/ash.2021.167. Epub 2021 Jun 28. PMID: 34604864; PMCID: PMC8486290 FDA Drug Safety Communication. FDA. 2016. Accessed October 10, 2022 https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety[1]communication-fda-advises-restricting-fluoroquinolone-antibiotic-use-certain Anger J, Lee U, Ackerman AL, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2019;202(2):282-289. doi: 10.1097/JU.00000000000002963 Thompson J, Marijam A, Mitrani-Gold FS, Wright J, Joshi AV. Activity impairment and health-related emotional wellbeing associated with an uncomplicated urinary tract infection among US females. Oral presentation at: IDWeek 2021; September 29-October 3, 2021; Virtual Conference. Session: UTIs; presentation 196 7.Colgan R, Keating K, Dougouih M. Survey of symptom burden in women with uncomplicated urinary tract infections. Clin Drug Investig. 2004;24(1):55-60. doi: 10.2165/00044011-200424010-00007 Thompson J, Marijam A, Mitrani-Gold FS, Wright J, Joshi AV. A survey study of healthcare resource use, and direct and indirect costs, among females with an uncomplicated urinary tract infection in the United States. Poster presented at: IDWeek 2021; September 29-October 3, 2021. Poster 1227 Grigoryan L, Mulgirigama A, Powell M, Schmiemann G. The emotional impact of urinary tract infections in women: a qualitative analysis. BMC Womens Health. 2022;22(1):182. doi: 10.1186/s12905-022-01757-3 Scott VC, Thum LW, Sadun T, et al. Fear and frustration among women with recurrent urinary tract infections: findings from patient focus groups. J Urol. 2021;206(3):688-695. doi: 10.1097/JU.0000000000001843 Lecky DM, Howdle J, Butler CC, McNulty CA. Optimising management of UTIs in primary care: a qualitative study of patient and GP perspectives to inform the development of an evidence-based, shared decision-making resource. Br J Gen Pract. 2020;70(694):e330-e338. doi: 10.3399/bjgp20X708173 Chwa A, Kavanagh K, Linnebur SA, Fixen DR. Evaluation of methenamine for urinary tract infection prevention in older adults: a review of the evidence. Ther Adv Drug Saf. 2019;10:2042098619876749. Published 2019 Sep 23. doi:10.1177/2042098619876749 Harding C, Mossop H, Homer T, etal. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial. BMJ 2022;376:e068229. doi: 10.1136/bmj-2021-0068229 Wade C, et al. Methenamine Prophylaxis for Recurrent Urinary Tract Infections in a Tertiary Referral Center. Urol Pract 2021;8(8):699-704 Hoffmann TC. Methenamine hippurate for recurrent urinary tract infections. BMJ 2022; 376 De Paepe H, Hoebeke P, Renson C, et al. Pelvic-floor therapy in girls with recurrent urinary tract infections and dysfunctional voiding. Br J Urol. 1998;81 Suppl 3:109-113. doi:10.1046/j.1464-410x.1998.00021.x Hooton TM, Vecchio M, Iroz A et al. Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections. JAMA Intern Med 2018; 178: 1509 Gupta K, Hooton TM, Naber KG, et al.; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-e120. doi: 10.1093/cid/ciq257
The controversy surrounding whether to collect urine cultures and which empiric treatment to prescribe in patients with uncomplicated UTI has left many clinicians unsure of the right approach. In this the first episode of a podcast series, we'll discuss the definition of clinical cure and dive into the evidence behind grey areas in the diagnosis and management of uncomplicated UTI. Disclaimers: This presentation is sponsored by GSK. The speakers are GSK paid healthcare providers. The content is intended to support disease state education and is considered nonpromotional. The content and views expressed therein do not necessarily reflect the views, policies, or position of Pri-Med. This program is limited to Health Care Professionals (HCPs) only. GSK complies with all state and federal laws including transparent reporting and disclosure of payments and transfers of value to HCPs. References: Gupta K, Hooton TM, Naber KG, et al.; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103- e120. doi: 10.1093/cid/ciq2572. Anger J, Lee U, Ackerman AL, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2019;202(2):282-289. doi: 10.1097/JU.00000000000002963 Houlbar M, Meng L. SHC Clinical Pathway: Inpatient Management of Urinary Tract Infections – Adult Patients. Stanford Antimicrobial Safety and Sustainability Program. November 2017. https://med.stanford.edu/content/dam/sm/bugsanddrugs/documents/c linicalpathways/SHC-UTI-Inpatient-Guideline.pdf. Accessed November 30, 2022. Hooton TM, Gupta K. Acute simple cystitis in women. UpToDate. Updated March 15, 2021. Accessed November 9, 2022. https://www.uptodate.com/contents/acute-simple-cystitis-in-women Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011;84(7):771-776. Shafrin J, Marijam A, Joshi AV, et al. Impact of suboptimal or inappropriate treatment on healthcare resource use and cost among patients with uncomplicated urinary tract infection: an analysis of integrated delivery network electronic health records. Antimicrob Resist Infect Control. 2022;11(1):133. Published 2022 Nov 4. doi:10.1186/s13756-022-01170-3 Daneman N, Chateau D, Dahl M, et al. Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study. Clin Microbiol Infect. 2020;26(5):613-618. doi:10.1016/j.cmi.2019.10.016 Bratsman A, Mathias K, Laubscher R, Grigoryan L, Rose S. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning. Pharmacoepidemiol Drug Saf. 2020;29(6):701-707. doi:10.1002/pds.5018 FDA Drug Safety Communication. FDA. 2019. Accessed October 10, 2022 https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns[1]about-increased-risk-ruptures-or-tears-aorta-blood-vessel[1]fluoroquinolone-antibiotics Nicolle LE; AMMI Canada Guidelines Committee*. Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol. 2005;16(6):349- 360. doi:10.1155/2005/385768
If you haven't thought about copper in a while, you're overdue! Wilson's Disease is one of the rare conditions with nutrition implications. The condition impacts how the body processes copper. Join Sara and Lyndel to dust off nutrition recommendations for this not-too-common condition. Show Notes: Bandmann O, Weiss KH, Kaler SG. Wilson's disease and other neurological copper disorders. Lancet Neurol. 2015;14(1):103-113. Brewer GJ. Wilson disease. NORD website. Accessed October 10, 2022: https://bit.ly/2G7drf8 Low copper diet for Wilson's disease. GI Resources website. Accessed October 10, 2022: https://bit.ly/3G37YCp Teufel-Schäfer U, Forster C, Schaefer N. Low copper diet—a therapeutic treatment option for Wilson's Disease? Children. 2022;9(8):1132.
The Cleveland Torso Murders, brought to you by Alaina!!! This is definitely a gnarly case that dates back to the 1930s when torsos started popping up left and right. Many bodies were never identified and to this day the identity of the Mad Butcher is unknown. Part 1 will cover the first six bodies to turn up in the area of Kingsbury Run and will touch upon the arrival of a fancy new inspector in town to lead the case. Thank you to our beautiful David White for research assistance! References:Badal, James J. 2014. In the Wake of the Butcher: Cleveland's Torso Murders. Kent, Ohio: Kent State University Press.—. 2022. The Kingsbury Run Murders. Accessed October 10, 2022.Collins, Max Allen, and A. Brad Schwartz. 2020. Eliot Ness and the Mad Butcher. Boston, MA: Mariner Books.Lytle, Alea. n.d. Kingsbury Run. Accessed October 12, 2022. https://clevelandhistorical.org/items/show/376.Plainesville Telegraph. 1934. "Police Seek to Trace Operation as Key to Torso Murder Mystery." Plainesville Telegraph, September 6.The El Reno Daily Tribune. 1935. "Decapitated Body is Discovered in Ravine." The El Reno Daily Tribune, September 24: 1.Toledo News-Bee. 1936. "Cleveland Maniac Hnuted in Murders." The Cleveland News-Bee, June 6.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Marguerite Alibert was a woman set on getting what she wanted out of life. She was raised a very poor girl and was sent away from her family at a very young age to go and live with the Sisters of Mary. When she became pregnant at 16 and lost the job they had set up for her she was left all alone in the world and had to turn to sex work to make a living. She ended up being one of the most popular and desired courtesans in Paris, but that reputation would not remain spotless for long. Soon Marguerite, after scamming multiple men… like Prince Edward VIII, would meet a young Egyptian “Prince.” Their life was set up to be picture perfect, but all was not as it seemed. Just six months into their marriage, one of them would end up murdered. Thank you to David White for research assistance!Resources:Aberdeen Press and Journal. 1923. "Fahmy Trial." Aberdeen Press and Journal, September 14: 8.Nottingham Evening Post. 1923. "Fahmy's Fate." Nottingham Evening Post, September 14: 1.Rose, Andrew. 2013. The Woman Before Wallis: Prince Edward, the Parisian Courtesan, and the Perfect Murder. London: Picador.Shaw, Charles Gray. 1923. "Why a Woman Can Madly Love the Man She Kills for Hate." San Francisco Examiner, August 26.The Daily Mail. 1923. "Madame Fahmy Set Free." The Daily Mail, September 15: 4.The Dundee Courier. 1923. "Story of Broken Romance Behind London Hotel Tragedy." The Dundee Courier, September 11: 5.—. 1923. "Warning Sent to "Princess"." The Dundee Courier, September 12: 5.The Evening Telegraph. 1923. "No Will Left By Fahmy." The Evening Telegraph, September 17: 2.World Economic Forum. 2014. Open borders: WW1's forgotten casualty. June 27. Accessed October 20, 2022. https://www.weforum.org/agenda/2014/06/open-borders-ww1s-forgotten-casualty/.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
(Matthew 5:4) Yearly Theme: “Patience is…” Series Title: “Good Grief” November 6th, 2022 Follow along in the Bible App: http://bible.com/events/48979894 We begin a new series today entitled “Good Grief,” and our subject matter is… you guessed it: Grief. But what is grief in its simplest form according to the dictionary? As a noun grief means – “keen mental suffering or distress over affliction or loss; sharp sorrow; painful regret.”[1] As we explore grief today, I thought it fitting to look to Jesus’ words of blessing and comfort in the Sermon on the Mount, specifically the Beatitudes. [1] “Grief Definition & Meaning.” Dictionary.com. Dictionary.com. Accessed October 27, 2022. https://www.dictionary.com/browse/grief.
On wisdom and conflict. Aleister Crowley (2004). The Book of Thoth. York Beach, ME: Weiser. Maa-kheru (2017). The forty-eight calls or keys, https://tinyurl.com/35ed6yyr (hermetic.com). Accessed October 2022. Bernadette Roberts (1991). The Path to No-Self: Life at the Center. Albany, NY: State University of New York (p. 91). Bernadette Roberts (2005). What is Self? A Study of the Spiritual Journey in Terms of Consciousness. Boulder, CO: Sentient (p. 181). Details of my other podcasts: https://oeith.co.uk/podcasts/ Support the podcast and access additional content at: https://patreon.com/oeith. Buy me a coffee at https://ko-fi.com/oeith or https://www.buymeacoffee.com/dbarfordG. Or you could send me a lovely book from https://www.amazon.co.uk/hz/wishlist/ls/1IQ3BVWY3L5L5?ref_=wl_share. Hosted on Acast. See acast.com/privacy for more information.
This week on Pharm5: Imjudo (tremelimumab) FDA approved Tecvayli (teclistamab-cqyv) FDA approved Cancer incidence up, mortality down Pharmacies administered >50% of COVID vaccines AGA Obesity Treatment Guidelines Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Imjudo (tremelimumab) in combination with Imfinzi approved in the US for patients with unresectable liver cancer. AstraZeneca. https://bit.ly/3NevJKX. Published October 24, 2022. Accessed October 27, 2022. Abou-Alfa GK, Lau G, Kudo M, et al. Tremelimumab Plus durvalumab in unresectable hepatocellular carcinoma. NEJM Evidence. 2022;1(8). doi:10.1056/evidoa2100070 Center for Drug Evaluation and Research. FDA approves teclistamab-cqyv for relapsed or refractory multiple myeloma. U.S. Food and Drug Administration. https://bit.ly/3zqMixF. Accessed October 27, 2022. Cronin KA, Scott S, Firth AU, et al. Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer. October 2022. doi:10.1002/cncr.34479 Hunter E. Overall cancer death rates have declined, but rates among racial/ethnic minorities have not followed suit. Pharmacy Times. https://bit.ly/3gPg4G0. Published October 27, 2022. Accessed October 27, 2022. Grabenstein JD. Essential services: Quantifying the contributions of America's pharmacists in COVID-19 clinical interventions. Journal of the American Pharmacists Association. 2022. doi:10.1016/j.japh.2022.08.010 @JAPhAJournal. IN PRESS: Pharmacists delivered over 350 million clinical interventions during COVID pandemic. #TwitteRx #pharmacists #COVID19. Posted October 25, 2022. Accessed October 27, 2022. https://bit.ly/3U1xn4N. Grunvald E, Shah R, Hernaez R, et al. AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology. 2022;163(5):1198-1225. doi:10.1053/j.gastro.2022.08.045
On the ways in which everyone practises magick.Anonymous (2002). Meditations on the Tarot: A Journey into Christian Hermeticism. New York: Tarcher.Geoffrey Chaucer (2022). The Franklin's Prologue and Tale, https://tinyurl.com/bdzyw98v (harvard.edu). Accessed October, 2022.Richard Kaczynski (2010). Perdurabo: The Life of Aleister Crowley, revised and expanded edition. Berkeley, CA: North Atlantic. (The letter from Crowley to Parsons is quoted on page 558.)Details of my other podcasts: https://oeith.co.uk/podcasts/Support the podcast and access additional content at: https://patreon.com/oeith. Buy me a coffee at https://ko-fi.com/oeith or https://www.buymeacoffee.com/dbarfordG. Or you could send me a lovely book from https://www.amazon.co.uk/hz/wishlist/ls/1IQ3BVWY3L5L5?ref_=wl_share. Hosted on Acast. See acast.com/privacy for more information.
This week on Pharm5: Eliquis v. Xarelto for AFib Improve M&M by quickly titrating HFrEF treatments National Adderall shortage Novavax ok'd as booster Student loan forgiveness application Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Dawwas GK, Cuker A, Barnes GD, Lewis JD, Hennessy S. Apixaban versus rivaroxaban in patients with atrial fibrillation and valvular heart disease. Annals of Internal Medicine. October 2022. doi:10.7326/m22-0318 Strong-HF study in patients admitted for acute heart failure (HF) terminated early for superior efficacy. STRONG-HF study in patients admitted for acute heart failure (HF) terminated early for superior efficacy. https://prn.to/3sbDrMv. Published October 13, 2022. Accessed October 14, 2022. Safety, tolerability, and efficacy of rapid optimization, helped by NT-probnp testing, of heart failure therapies - full text view. Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies - Full Text View - ClinicalTrials.gov. https://bit.ly/3MQktVd. Accessed October 14, 2022. Brooks M. FDA confirms nationwide Adderall shortage. Medscape. https://wb.md/3DfXS0O. Published October 14, 2022. Accessed October 14, 2022. FDA drug shortages. FDA. https://bit.ly/3yZiAzG. Accessed October 14, 2022. CDC allows Novavax monovalent COVID-19 boosters for adults ages 18 and older. Centers for Disease Control and Prevention. https://bit.ly/3VM10J9. Published October 19, 2022. Accessed October 20, 2022. Center for Biologics Evaluation and Research. Novavax COVID-19 vaccine. U.S. Food and Drug Administration. https://bit.ly/3eMcbkC. Accessed October 20, 2022. Federal Student Aid. https://bit.ly/3ToNLwC. Accessed October 20, 2022. Duster C. How to qualify for Biden's new student loan forgiveness plan. CNN Politics. https://cnn.it/3ALjKjF. Published Wednesday August 24, 2022. Accessed August 24, 2022. Occupational Employment and Wages, May 2021 - Pharmacists. U.S. Bureau of Labor Statistics. https://bit.ly/3PObHXm. Published March 31, 2022. Accessed August 24, 2022. Smoot C. What is the average pharmacy school debt in 2022? SuperMoney. https://bit.ly/3PHqZNK. Published April 26, 2022. Accessed August 24, 2022.
EPISODE NOTES: Everyone loves a good ghost story, so settle in and snuggle up as today's episode examines the story of a heartbroken bride to be, an iron-willed business man, and a haunted wedding dress! Support us at :https://www.patreon.com/historyunhemmedhttps://anchor.fm/historyunhemmed/support Follow us on: Instagram: @history_unhemmed Facebook: History Unhemmed Thank you!
This week on Pharm5: Pharmacy Technician Day Boostrix during pregnancy AMA reviews PBMs COVID boosters for kids ISMP guidance for pharmacists in codes Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Pharmacy technician day. ASHP. https://bit.ly/3exFuaj. Accessed October 13, 2022. 29-2052 pharmacy technicians. U.S. Bureau of Labor Statistics. https://bit.ly/3VuX0wr. Published March 31, 2022. Accessed October 13, 2022. Resume CV development. ASHP. https://bit.ly/3EGX2LY. Accessed October 13, 2022. FDA approves vaccine for use during third trimester of pregnancy to prevent whooping cough in infants younger than two months of age. U.S. Food and Drug Administration. https://bit.ly/3CAlc82. Accessed October 13, 2022. New AMA report calls for state regulation of drug price middlemen. Yahoo! Finance. https://yhoo.it/3rWe0hQ. Accessed October 13, 2022. Guardado JR. AMA. Competition in Commercial PBM Markets and Vertical Integration of Health Insurers with PBMs. https://bit.ly/3MwDSdx. Accessed October 13, 2022. Coronavirus (COVID-19) update: FDA authorizes Moderna and Pfizer-BioNTech bivalent COVID-19 vaccines for use as a booster dose in younger age groups. U.S. Food and Drug Administration. https://bit.ly/3TiXjZA. Accessed October 13, 2022. CDC Covid Data tracker. Centers for Disease Control and Prevention. https://covid.cdc.gov/covid-data-tracker/#demographicsovertime. Accessed October 13, 2022. Survey results from pharmacists provide support to enhance the organizational response to codes. Institute For Safe Medication Practices. https://bit.ly/3gaqejW. Published October 6, 2022. Accessed October 13, 2022.
This week on Pharm5: ProAir HFA discontinued New MPJE blueprint PREP Act Expansion Ebola outbreak in Uganda American Pharmacists Month Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References ProAir HFA®. Albuterol Inhalers. https://bit.ly/3CfEpvB. Accessed October 6, 2022. ProAir manufacturer discontinuation. NC Medicaid. https://bit.ly/3Vm54Qn. Accessed October 6, 2022. Home Page: Department of Vermont health access. Home Page | Department of Vermont Health Access. https://bit.ly/3Mayn45. Accessed October 6, 2022. Multistate Pharmacy Jurisprudence Examination (MPJE): NABP. National Association of Boards of Pharmacy. https://bit.ly/3RJpYWz. Published October 6, 2022. Accessed October 6, 2022. HHS amends prep act declaration increasing workforce authorized to administer monkeypox vaccines. https://bit.ly/3MbuX0V. Accessed October 6, 2022. JYNNEOS vaccine fact sheet - EZIZ. https://bit.ly/3V8zvJx. Accessed October 7, 2022. Daniel R. Lucey MD. Uganda ebola outbreak grows to more than 60 cases, 882 contacts and a fourth district. IDSA Home. https://bit.ly/3RXIavL. Accessed October 6, 2022. Ebola virus disease. World Health Organization. https://bit.ly/3T68x3d. Accessed October 6, 2022. American Pharmacists Month. APhM. https://bit.ly/3CEncNK. Accessed October 6, 2022. Pharmacy technician day. ASHP. https://bit.ly/3rCTN0f. Accessed October 6, 2022.
Are benzos effective for treating anxiety? Insomnia? Seizures? If they aren't safe, what is the evidence? How many BIND symptoms are there? Could these be permanent? And what about COVID? Tune in for the surprising answers.In today's episode, we ask some key questions about benzos and provide real answers, with evidence to back them. We also share questions from our international listeners on CBD and probiotics, and we hear a powerful story of one woman's struggle with her third attempt at withdrawal. This one if chock full of information, and I hope you'll join us.https://www.easinganxiety.com/post/the-facts-what-do-we-really-know-about-benzos-and-bind-bfp107Video ID: BFP107Chapters 0:00:00 INTRODUCTION0:01:16 About the Last Episode0:02:17 Behind the Scenes Work0:03:18 Hurricane Ian0:05:38 MAILBAG0:05:54 Benzo Belly and Probiotics (Jon)0:11:48 CBD and Withdrawal (Julie)0:17:29 BENZO STORY (Jessica)0:26:48 Response from D0:31:20 FEATURE: Benzo Facts0:32:48 Are Benzos Effective?0:35:23 Are Benzos Safe?0:43:49 Can You Be Addicted to Benzos?0:44:46 Is BIND an Official Term?0:47:21 How Many BIND Symptoms Are There?0:52:05 Is BIND Permanent?0:56:42 Are Z-drugs the Same as Benzos?0:57:22 Do Benzos Have an Effect on COVID?1:00:58 MOMENT OF PEACE Episode Resources The following resource links are provided as a courtesy to our listeners. They do not constitute an endorsement by Easing Anxiety of the resource or any recommendations or advice provided therein.SITE RESOURCES— Benzodiazepine Action Work Group (BAWG) — https://benzoaction.org— Benzodiazepine Information Coalition (BIC) — https://benzoinfo.com— The Alliance for Benzodiazepine Best Practices — https://benzoreform.org— Blazing Benzos Facebook Group — https://m.facebook.com/groups/1205287192817668/MAILBAGGrinspoon, Peter. Cannabidiol (CBD): What we know and what we don't. Harvard Health Publishing. September 24, 2021. Accessed September 27, 2022. https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476. FEATUREAshton, C. Heather. Benzodiazepines: How They Work and How to Withdraw (aka The Ashton Manual). 2002. Accessed April 13, 2016. http://www.benzo.org.uk/manual. Ashton, C. Heather. Benzodiazepines: The Still Unfinished Story. (Speech at Beat the Benzos Launch Conference, Croyden, London, England). https://www.benzo.org.uk/ashspeech.htm. Bachhuber, Marcus A., Sean Hennessy, Chinazo O. Cunningham and Joanna L. Starrels. “Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013.” American Journal of Public Health (AJPH) (April 2016). Accessed April 7, 2018. doi:10.2105/AJPH.2016.303061. Benzodiazepine Information Coalition (BIC). Withdrawal & Post Withdrawal Symptoms. Accessed September 29, 2022. https://www.benzoinfo.com/benzodiazepine-withdrawal-post-withdrawal-symptoms/. Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJC, Furukawa TA, Koesters M. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No.: CD010677. DOI: 10.1002/14651858.CD010677.pub2. Accessed 27 September 2022. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010677.pub2/full. Commonwealth of Pennsylvania. Prescribing Guidelines for Pennsylvania: Safe Prescribing Benzodiazepines for Acute Treatment of Anxiety & Insomnia. Updated May 15, 2017. Accessed April 7, 2018. http://www.health.pa.gov/My%20Health/Diseases%20and%20Conditions/M-P/opioids/Documents/PA%20Guidelines%20on%20Benzo%20Prescribing.pdf. Easing Anxiety. BIND Symptoms. https://easinganxiety.com/symptoms. Foster, D E. Benzo Free: The World of Anti-Anxiety Drugs and the Reality of Withdrawal. Erie, CO: Denim Mountain Press, 2018. https://easinganxiety.com/book. Frances, Allen. Yes, Benzos Are Bad for You. Pro Talk: A Rehabs.com Community. June 10, 2016. Accessed October 13, 2016. https://www.rehabs.com/pro-talk-articles/yes-benzos-are-bad-for-you/. Guina J, Merrill B. Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives. J Clin Med. 2018 Jan 30;7(2):17. doi: 10.3390/jcm7020017. PMID: 29385731; PMCID: PMC5852433. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852433/. Kripke, D. F., R.D. Langer and L.E. Kline. Hypnotics' Association with Mortality or Cancer: A Matched Cohort Study. BMJ Open 2(e000850)(2012). Accessed June 21, 2017. doi:10.1136/bmjopen-2012-000850. Lakhani, Nina, Drugs Linked to Brain Damage 30 Years Ago, Independent, November 7, 2010, accessed March 4, 2017, https://www.independent.co.uk/life-style/health-and-families/health-news/drugs-linked-to-brain-damage-30-years-ago-2127504.html. New York City Department of Health and Mental Hygiene (NYC DOHMH). City Health Information: Judicious Prescribing of Benzodiazepines. 35(2)(2016). https://docs.wixstatic.com/ugd/990dad_167113513c9445f8bc77a77370ce649f.pdf. Park, H.Y., Kwon, J., An, S.K. et al. A nationwide cohort study of the association of benzodiazepines with SARS-CoV-2 infection and clinical outcomes. Sci Rep 12, 15947 (2022). https://doi.org/10.1038/s41598-022-20335-z. U.S. Drug Enforcement Agency (DEA). Office of Diversion Control; Drug & Chemical Evaluation Section: Benzodiazepines (January 2013). Accessed March 6, 2017. https://www.deadiversion.usdoj.gov/drug_chem_info/benzo.pdf. U.S. Food & Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. September 23, 2020. Accessed September 27, 2022. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class. The PodcastThe Benzo Free Podcast provides information, support, and community to those who struggle with the long-term effects of anxiety medications such as benzodiazepines (Xanax, Ativan, Klonopin, Valium) and Z-drugs (Ambien, Lunesta, Sonata). WEBSITE: https://www.easinganxiety.comMAILING LIST: https://www.easinganxiety.com/subscribe YOUTUBE: https://www.youtube.com/@easinganx DISCLAIMERAll content provided by Easing Anxiety is for general informational purposes only and should never be considered medical advice. Any health-related information provided is not a substitute for medical advice and should not be used to diagnose or treat health problems, or to prescribe any medical devices or other remedies. Never disregard medical advice or delay in seeking it. Please visit our website for our complete disclaimer at https://www.easinganxiety.com/disclaimer. CREDITSMusic provided / licensed by Storyblocks Audio — https://www.storyblocks.com Benzo Free Theme — Title: “Walk in the Park” — Artist: Neil Cross PRODUCTIONEasing Anxiety is produced by… Denim Mountain Presshttps://www.denimmountainpress.com ©2022 Denim Mountain Press – All Rights Reserved
In the opening episode of season three, Alejandra introduces the season's theme "practice" with a refection on her own fieldwork experience, and the ways in which she saw her own practices mirrored in those of her participants. Works Cited:Asad, Talal, ed. 1973. Anthropology and the Colonial Encounter. Atlantic Highlands, NJ: Humanities Press.Castaing-Taylor, Lucian and Ilisa Barbash, directors. 2009. Sweetgrass. Cinema Guild.Clifford, James, and George E. Marcus. 1986. Writing Culture: The Poetics and Politics of Ethnography. Berkeley, CA: University of California Press.Flaherty, Robert, director. 1922. Nanook of the North. Pathé Exchange.Haraway, Donna. 1984. “Teddy Bear Patriarchy: Taxidermy in the Garden of Eden.” Social Text 11: 20-64.Itano, Nicole, and Paul Harvey. 2020. “Our Planet: Our Impact.” WWF Report. https://www.wwf.org.uk/sites/default/files/2020-09/wwfuk_our%20planet%20impact%20report_final.pdf.MacDougall, David, and Judith MacDougall, directors. 1982. A Wife Among Wives. Berkeley Media. https://video.alexanderstreet.com/watch/a-wife-among-wives.MacDougall, David. 2005. The Corporeal Image: Film, Ethnography, and the Senses. Princeton, NJ: Princeton University Press.Mead, Margaret, and Gregory Bateson. 1951. “Trance and Dance in Bali.” Video. Library of Congress, Washington, D.C. 20540 USA. Accessed October 18, 2021. https://www.loc.gov/item/mbrs02425201/.Mead, Margaret, and Gregory Bateson. 1977. “Margaret Mead and Gregory Bateson the Use of the Camera in Anthropology” Studies on the Anthropology of Visual Communication 4(2): 78-80.
Welcome to Episode 10 of “The 2 View,” the podcast for EM and urgent care nurse practitioners and physician assistants! Show Notes for Episode 10 of “The 2 View” – Skipping a Beat, Strep Throat, Hyperthyroidism and TSH, and More… Skipping a Beat: Zio Patch and Loop Recorders Barrett PM, Komatireddy R, Haaser S, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. PubMed.gov. Published January 2014. Accessed October 6, 2021. https://pubmed.ncbi.nlm.nih.gov/24384108/ Burke J, Haigney MCP, Borne R, Krantz MJ. Smartwatch detection of ventricular tachycardia: Case series. HeartRhythm Case Rep. NCBI. Published October 2020. Accessed October 6, 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573479/ Elsinger F, Smithuis R, Spijkerboer A. Cardiovascular devices on Chest X-Ray. Radiology Assistant. Radiologyassistant.nl. Published December 1, 2018. Accessed October 6, 2021. https://radiologyassistant.nl/cardiovascular/devices/cardiovascular-devices Elsinger F, Smithuis R, Spijkerboer A. Cardiovascular devices on Chest X-Ray. Radiology Assistant. Radiologyassistant.nl. Published December 1, 2018. Accessed October 6, 2021. https://radiologyassistant.nl/cardiovascular/devices/cardiovascular-devices#loop-recorders iRhythm Technologies, Inc. Why Zio. Irhythmtech.com. Accessed October 6, 2021. https://www.irhythmtech.com/patients/why-zio Loop Recorder Implantation. Johns Hopkins Medicine. Hopkinsmedicine.org. Accessed October 6, 2021. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/loop-recorder-implantation Yenikomshian M, Jarvis J, Patton C, et al. Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review. Curr Med Res Opin. Taylor & Francis Online. Published May 28, 2019. Accessed October 6, 2021. https://www.tandfonline.com/doi/full/10.1080/03007995.2019.1610370 Hyperthyroidism and TSH Collection Tubes and Description. Additive B, Color/Volume U. COLLECTION TUBES AND DESCRIPTION. NYU Langone Medical Center. Testmenu.com. Accessed October 6, 2021. https://www.testmenu.com/nyumc/TestDirectory/SiteFile?fileName=sidebar%5Ccollection%20tubes%20and%20descriptions.pdf Graves' disease. Mayo Clinic. Mayoclinic.org. Accessed October 6, 2021. https://www.mayoclinic.org/diseases-conditions/graves-disease/symptoms-causes/syc-20356240 Plasma Separation: Why Do You Need It? How Do You Achieve It? DCN Dx. Dcndx.com. Published July 17, 2019. Accessed October 6, 2021. https://dcndx.com/plasma-separation-why-you-need-it/ What are Normal Thyroid Hormone Levels? UCLA Health. Uclahealth.org. Accessed October 6, 2021. https://www.uclahealth.org/endocrine-center/normal-thyroid-hormone-levels Mike & Martha's Something Sweet Home - National APP week. Nationalappweek.com. Published July 9, 2021. Accessed October 6, 2021. http://www.nationalappweek.com Recurring Sources Center for Medical Education. Ccme.org. http://ccme.org The Proceduralist. Theproceduralist.org. http://www.theproceduralist.org The Procedural Pause. Emergency Medicine News. Lww.com. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx The Skeptics Guide to Emergency Medicine. Thesgem.com. http://www.thesgem.com Trivia Question: Send answers to 2viewcast@gmail.com Last month we asked you a trivia question regarding food and the manufacturing of war weaponry. It was another 2-part question and we asked: During what war were Americans urged to save this food fat so that it could be used to manufacture bombs? The answer was: World War II and bacon. Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to. We hope to see you at the November Original EM Boot Camp LIVE in Las Vegas!
Do you have questions about benzos? About withdrawal? About how fast you should taper? Or if your exercise is making things worse? Wonder if you can sue? Or do you just want some tips on managing your fear? Either way, this is the episode for you. In today's episode, we open our mailbag for questions, comments, and feedback from you the listener. You are the heart of this podcast, and our best episodes are the ones where I can share your concerns and insights. I also share some successes and struggles from my week in the mountains and announce our upcoming interview. I hope you enjoy it. https://www.easinganxiety.com/post/our-mailbag-muscles-tapering-and-lawsuits-bfp086Video ID: BFP086 Chapters 00:00 INTRODUCTION09:37 MAILBAG Intro11:28 Flumazenil Correction15:26 How Fast Should I Taper?22:22 Addiction, Dependence, and Fear25:38 When Can People Sue?29:58 Exercise and Muscle Symptoms33:45 Managing the Fear41:12 MOMENT OF PEACE Resources The following resource links are provided as a courtesy to our listeners. They do not constitute an endorsement by Easing Anxiety of the resource or any recommendations or advice provided therein. MAILBAG Ashton, C. Heather. “Benzodiazepines: How They Work and How to Withdraw (aka The Ashton Manual).” 2002. Accessed April 13, 2016. http://www.benzo.org.uk/manual.Foster, D E. “Benzo Free: The World of Anti-Anxiety Drugs and the Reality of Withdrawal.” Erie, CO: Denim Mountain Press, 2018. https://easinganxiety.com/book. King, M.B. “Is There Still a Role for Benzodiazepines in General Practice?” British Journal of General Practice 42 (358): 202–5. Accessed March 6, 2017. PMC 1372025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1372025/pdf/brjgenprac00056-0028.pdf.Waters, Jo, “Why Are 250,000 Lives Still Being Ruined by Mother's Little Helpers? Doctors Finally Admit Too Many Patients Are Hooked on Tranquilisers.” Daily Mail. November 7, 2016. Accessed December 22, 2016, http://www.dailymail.co.uk/health/article-3915114/Why-250-000-lives-ruined-mother-s-little-helpers-Doctors-finally-admit-patients-hooked-tranquilisers.html#.White, Caroline. “Be Careful When Prescribing Benzodiazepines, Doctors Warned.” OnMedica. October 26, 2016. Accessed October 26, 2016. http://www.onmedica.com/newsArticle.aspx?id=bc9d74e2-4bd2-4792-b1d3-e154f4fe4bb5. The PodcastThe Benzo Free Podcast provides information, support, and community to those who struggle with the long-term effects of anxiety medications such as benzodiazepines (Xanax, Ativan, Klonopin, Valium) and Z-drugs (Ambien, Lunesta, Sonata). WEBSITE: https://www.easinganxiety.comMAILING LIST: https://www.easinganxiety.com/subscribe YOUTUBE: https://www.youtube.com/@easinganx DISCLAIMERAll content provided by Easing Anxiety is for general informational purposes only and should never be considered medical advice. Any health-related information provided is not a substitute for medical advice and should not be used to diagnose or treat health problems, or to prescribe any medical devices or other remedies. Never disregard medical advice or delay in seeking it. Please visit our website for our complete disclaimer at https://www.easinganxiety.com/disclaimer. CREDITSMusic provided / licensed by Storyblocks Audio — https://www.storyblocks.com Benzo Free Theme — Title: “Walk in the Park” — Artist: Neil Cross Meditation Music— Title: “Music Design (Yesterday)”— Artist: Jason Inc. PRODUCTIONEasing Anxiety is produced by…Denim Mountain Presshttps://www.denimmountainpress.com ©2022 Denim Mountain Press – All Rights Reserved
Share this post with others: Do you have questions about benzos? About withdrawal? About how fast you should taper? Or if your exercise is making things worse? Wonder if you can sue? Or do you just want some tips on managing your fear? Either way, this is the episode for you. In today's episode, we open our mailbag for questions, comments, and feedback from you the listener. You are the heart of this podcast, and our best episodes are the ones where I can share your concerns and insights. I also share some successes and struggles from my week in the mountains and announce our upcoming interview. I hope you enjoy it. Welcome to Episode #86 Today, we return to our mailbag and pull out six questions and comments to share and hopefully, answer. We talk about tapering rates, lawsuits, fear, addiction and dependence, exercise, muscle spasms, and so much more. I also share my recent trip to Vail, Colorado for a wedding and a wonderful window that reminded me of the good times, worry-free. I hope you enjoy it. Video ID: BFP086 Chapters 00:00 INTRODUCTION09:37 MAILBAG Intro11:28 Flumazenil Correction15:26 How Fast Should I Taper?22:22 Addiction, Dependence, and Fear25:38 When Can People Sue?29:58 Exercise and Muscle Symptoms33:45 Managing the Fear41:12 MOMENT OF PEACE Episode Resources The following resource links are provided as a courtesy to our listeners. They do not constitute an endorsement by Benzo Free of the resource or any recommendations or advice provided therein. MAILBAG • Ashton, C. Heather. “Benzodiazepines: How They Work and How to Withdraw (aka The Ashton Manual).” 2002. Accessed April 13, 2016. http://www.benzo.org.uk/manual.• Foster, D E. “Benzo Free: The World of Anti-Anxiety Drugs and the Reality of Withdrawal.” Erie, CO: Denim Mountain Press, 2018. https://www.benzofree.org/book.• King, M.B. "Is There Still a Role for Benzodiazepines in General Practice?" British Journal of General Practice 42 (358): 202–5. Accessed March 6, 2017. PMC 1372025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1372025/pdf/brjgenprac00056-0028.pdf.• Waters, Jo, "Why Are 250,000 Lives Still Being Ruined by Mother's Little Helpers? Doctors Finally Admit Too Many Patients Are Hooked on Tranquilisers." Daily Mail. November 7, 2016. Accessed December 22, 2016, http://www.dailymail.co.uk/health/article-3915114/Why-250-000-lives-ruined-mother-s-little-helpers-Doctors-finally-admit-patients-hooked-tranquilisers.html#.• White, Caroline. "Be Careful When Prescribing Benzodiazepines, Doctors Warned." OnMedica. October 26, 2016. Accessed October 26, 2016. http://www.onmedica.com/newsArticle.aspx?id=bc9d74e2-4bd2-4792-b1d3-e154f4fe4bb5. Site Links VISIT US ONLINE— WEBSITE: https://www.easinganxiety.com— YOUTUBE (Easing Anxiety): https://www.youtube.com/easinganxiety— YOUTUBE (Benzo Free): https://www.youtube.com/benzofree— INSTAGRAM: https://www.instagram.com/easinganxiety PLEASE LET US KNOW WHAT YOU THINK— COMMENT: On this video in YouTube— COMMENT: On the blog post on our website— FEEDBACK FORM: https://www.easinganxiety.com/feedback— EMAIL: feedback@easinganxiety.com SUPPORT US— Make a Donation: https://www.easinganxiety.com/donate Podcast Summary This podcast is dedicated to those who struggle with side effects, dependence, and withdrawal from benzos, a group of drugs from the benzodiazepine and nonbenzodiazepine classes, better known as anti-anxiety drugs, sleeping pills, sedatives, and minor tranquilizers. Their common brand names include Ambien, Ativan, Klonopin, Lunesta, Valium, and Xanax. Feedback We'd love to hear from you! The Benzo Free Podcast is a community podcast and we need your input to help it grow and improve. You can tell us what you think in the following ways: Fill out our Feedback Form at https://www.easinganxiety.com/feedbackEmail us at feedback@easinganxiety.com Comment on one of our videos or posts. Disclaimer
How much do you know about benzos? About withdrawal? About anxiety and insomnia? Want to test that knowledge? Well, this is the place. It's time to lighten the mood a bit and have some fun. Welcome to our first-ever Benzo Trivia episode. In today's episode of the podcast, we ask the questions, and you provide the answers. I provide a series of questions in five separate categories related to benzos, allow you time to answer, and then provide the answers with a little background on each. I hope you enjoy it. https://www.easinganxiety.com/post/benzo-trivia-what-do-you-really-know-bfp085Video ID: BFP085 Chapters 00:00 Introduction 06:18 BENZO TRIVIA – Intro 08:49 Benzos, the Drug 16:50 Anxiety, Insomnia, and Benzos 21:30 The Benzo Community 24:51 Benzo Withdrawal 33:15 True or False: Rapid Fire 39:28 Closing Resources The following resource links are provided as a courtesy to our listeners. They do not constitute an endorsement by Easing Anxiety of the resource or any recommendations or advice provided therein. . FEATURE – BENZO TRIVIA American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders 4th ed. text rev. (DSM-IV-TR). Washington, DC: American Psychi-atric Association, 2000.Ashton, C. Heather. “Benzodiazepines: How They Work and How to Withdraw (aka The Ashton Manual).” 2002. Accessed April 13, 2016. http://www.benzo.org.uk/manual.Ashton, C. Heather. “Benzodiazepines: The Still Unfinished Story.” (Speech at Beat the Benzos Launch Conference, Croyden, London, England). https://www.benzo.org.uk/ashspeech.htm.Bachhuber, Marcus A., Sean Hennessy, Chinazo O. Cunningham and Joanna L. Starrels. “Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013.” American Journal of Public Health (AJPH) (April 2016). Accessed April 7, 2018. doi:10.2105/AJPH.2016.303061.Bowden, John. “CIA considered use of anti-anxiety drug in terror suspect interrogations: report.” The Hill. November 13, 2018. Accessed November 14, 2018. https://thehill.com/policy/defense/416485-cia-considered-potential-truth-serum-for-terror-suspects.Byrne, A. “Benzodiazepines: The End of a Dream.” Australian Family Physician 23(8)(Aug 1994):1584-5. Accessed April 17, 2018. https://www.ncbi.nlm.nih.gov/pubmed/7980158.Foster, D E. “Benzo Free: The World of Anti-Anxiety Drugs and the Reality of Withdrawal.” Erie, CO: Denim Mountain Press, 2018. https://easinganxiety.com/book.Frances, Allen. “Yes, Benzos Are Bad for You.” Pro Talk: A Rehabs.com Community, June 10, 2016. Accessed October 13, 2016. https://www.rehabs.com/pro-talk-articles/yes-benzos-are-bad-for-you/.Kripke, D. F., R.D. Langer and L.E. Kline. “Hypnotics' Association with Mortality or Cancer: A Matched Cohort Study.” BMJ Open 2(e000850)(2012). Accessed June 21, 2017. doi:10.1136/bmjopen-2012-000850.New York City Department of Health and Mental Hygiene (NYC DOHMH). City Health Information: Judicious Prescribing of Benzodiazepines 35(2)(2016). https://docs.wixstatic.com/ugd/990dad_167113513c9445f8bc77a77370ce649f.pdf.Porter, Mark, “Addicted to Sleeping Pills? Try This Instead,” The Sunday Times, October 25, 2016, accessed March 4, 2017, https://www.thetimes.co.uk/article/dr-mark-porter-how-to-avoid-sleeping-tablet-addiction-shsrnpwsm.Riechmann, Deb. “CIA considered potential truth serum for terror suspects.” Associated Press. November 13, 2018. Accessed November 14, 2018. https://apnews.com/e4bc055b4fee4e0d9f47ab14adc2c173.Sharbaf Shoar N, Bistas KG, Saadabadi A. “Flumazenil.” [Updated 2020 Sep 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK470180/.The PodcastThe Benzo Free Podcast provides information, support, and community to those who struggle with the long-term effects of anxiety medications such as benzodiazepines (Xanax, Ativan, Klonopin, Valium) and Z-drugs (Ambien, Lunesta, Sonata). WEBSITE: https://www.easinganxiety.comMAILING LIST: https://www.easinganxiety.com/subscribe YOUTUBE: https://www.youtube.com/@easinganx DISCLAIMERAll content provided by Easing Anxiety is for general informational purposes only and should never be considered medical advice. Any health-related information provided is not a substitute for medical advice and should not be used to diagnose or treat health problems, or to prescribe any medical devices or other remedies. Never disregard medical advice or delay in seeking it. Please visit our website for our complete disclaimer at https://www.easinganxiety.com/disclaimer. CREDITSMusic provided / licensed by Storyblocks Audio — https://www.storyblocks.com Benzo Free Theme — Title: “Walk in the Park” — Artist: Neil Cross PRODUCTIONEasing Anxiety is produced by…Denim Mountain Presshttps://www.denimmountainpress.com ©2022 Denim Mountain Press – All Rights Reserved
Share this post with others: How much do you know about benzos? About withdrawal? About anxiety and insomnia? Want to test that knowledge? Well, this is the place. It's time to lighten the mood a bit and have some fun. Welcome to our first-ever Benzo Trivia episode. In today's episode of the podcast, we ask the questions, and you provide the answers. I ask a series of questions in five separate categories related to benzos, allow you time to answer, and then provide the answers with a little background on each. I hope you enjoy it. Welcome to Episode #85 Today I decided to return to the studio and record a non-road-trip episode for once. And doing so, I also wondered if we should lighten the mood a bit. When I thought of options, trivia came to mind. So, here we are with our very first trivia episode for the Benzo Free Podcast. I ask a series of questions in five categories, and you answer, tallying up your score along the way. No pressure, just for fun. I hope you enjoy it. Video ID: BFP085 Chapters 00:00 Introduction06:18 BENZO TRIVIA – Intro08:49 Benzos, the Drug16:50 Anxiety, Insomnia, and Benzos21:30 The Benzo Community24:51 Benzo Withdrawal33:15 True or False: Rapid Fire39:28 Closing Episode Resources The following resource links are provided as a courtesy to our listeners. They do not constitute an endorsement by Benzo Free of the resource or any recommendations or advice provided therein. FEATURE - BENZO TRIVIA American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders 4th ed. text rev. (DSM-IV-TR). Washington, DC: American Psychi-atric Association, 2000.Ashton, C. Heather. “Benzodiazepines: How They Work and How to Withdraw (aka The Ashton Manual).” 2002. Accessed April 13, 2016. http://www.benzo.org.uk/manual.Ashton, C. Heather. "Benzodiazepines: The Still Unfinished Story." (Speech at Beat the Benzos Launch Conference, Croyden, London, England). https://www.benzo.org.uk/ashspeech.htm.Bachhuber, Marcus A., Sean Hennessy, Chinazo O. Cunningham and Joanna L. Starrels. "Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013." American Journal of Public Health (AJPH) (April 2016). Accessed April 7, 2018. doi:10.2105/AJPH.2016.303061.Bowden, John. “CIA considered use of anti-anxiety drug in terror suspect interrogations: report.” The Hill. November 13, 2018. Accessed November 14, 2018. https://thehill.com/policy/defense/416485-cia-considered-potential-truth-serum-for-terror-suspects.Byrne, A. "Benzodiazepines: The End of a Dream." Australian Family Physician 23(8)(Aug 1994):1584-5. Accessed April 17, 2018. https://www.ncbi.nlm.nih.gov/pubmed/7980158.Foster, D E. “Benzo Free: The World of Anti-Anxiety Drugs and the Reality of Withdrawal.” Erie, CO: Denim Mountain Press, 2018. https://www.benzofree.org/book.Frances, Allen. "Yes, Benzos Are Bad for You." Pro Talk: A Rehabs.com Community, June 10, 2016. Accessed October 13, 2016. https://www.rehabs.com/pro-talk-articles/yes-benzos-are-bad-for-you/.Kripke, D. F., R.D. Langer and L.E. Kline. "Hypnotics' Association with Mortality or Cancer: A Matched Cohort Study." BMJ Open 2(e000850)(2012). Accessed June 21, 2017. doi:10.1136/bmjopen-2012-000850.New York City Department of Health and Mental Hygiene (NYC DOHMH). City Health Information: Judicious Prescribing of Benzodiazepines 35(2)(2016). https://docs.wixstatic.com/ugd/990dad_167113513c9445f8bc77a77370ce649f.pdf.Porter, Mark, "Addicted to Sleeping Pills? Try This Instead," The Sunday Times, October 25, 2016, accessed March 4, 2017, https://www.thetimes.co.uk/article/dr-mark-porter-how-to-avoid-sleeping-tablet-addiction-shsrnpwsm.Riechmann, Deb. “CIA considered potential truth serum for terror suspects.” Associated Press. November 13, 2018. Accessed November 14, 2018. https://apnews.com/e4bc055b4fee4e0d9f47ab14adc2c173.Sharbaf Shoar N, Bistas KG, Saadabadi A. “Flumazenil.